Obesity due to excess calories

E4_OBESITYCAL

obesity: A disorder involving an excessive amount of body fat.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E66.00, E66.01 Cause of death: ICD-10 — E66.00, E66.01 2 out of 7 registries used, show all original rules.	23242
4. Check minimum number of events None	23242
5. Include endpoints None	23242
6. Filter based on genotype QC (FinnGen only)	23242

Control definitions (FinnGen only)

Control exclude: E4_OBESITY

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	E4_OBESITYCAL
CONTROL_EXCLUDE	E4_OBESITY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E660
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E660
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Obesity due to excess calories based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	139360	80833	57952
Only index persons	132586	77999	54587
Unadjusted period prevalence (%)
Whole population	2.02	2.32	1.62
Only index persons	2.54	2.87	2.08
Median age at first event (years)
Whole population	48.19	45.78	51.66
Only index persons	48.20	45.67	51.81

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	23242	15224	8018
Unadjusted period prevalence (%)	4.62	5.19	3.53
Median age at first event (years)	51.32	48.41	56.83

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
20487: Matched controls
204868

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M54.5

ICD-10 Finland

Low back pain

2.0

323.0

7252

44811

OAB72

NOMESCO Finland

Weight control and weight loss guidance

37.1

323.0

525

145

A10BX04

ATC

[U] exenatide; parenteral

23.5

323.0

651

286

C09AA02

ATC

enalapril; systemic

2.4

323.0

3660

17140

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

3.3

323.0

2567

8570

R5140

NOMESCO Finland

Monitoring the use of the aid

5.2

323.0

3813

8594

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

323.0

3209

14264

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.4

323.0

3932

18181

N06AX16

ATC

venlafaxine; oral

2.3

323.0

3462

16452

M79.6

ICD-10 Finland

Pain in limb

1.9

323.0

7516

47361

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.4

323.0

4151

19910

N02AX02

ATC

tramadol; systemic, rectal

2.3

323.0

9345

54487

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

3.2

323.0

3077

10823

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

323.0

6424

32698

A46

ICD-10 Finland

Erysipelas

3.2

323.0

3373

11730

G47.3

ICD-10 Finland

Sleep apnoea

6.7

323.0

8944

21202

E66.00

ICD-10 Finland

Metabolic syndrome

94.9

323.0

7679

1288

T90

ICPC

Diabetes non-insulin dependent

4.8

323.0

7248

20869

E66.01

ICD-10 Finland

Obesity due to excess calories

428.6

323.0

15266

1392

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

393.9

323.0

874

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

12.8

323.0

2675

2380

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.9

323.0

8025

23706

E11

ICD-10 Finland

Type 2 diabetes mellitus

4.4

323.0

4688

12810

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

6.5

323.0

8072

18717

WX722

NOMESCO Finland

PEEP

6.0

323.0

1684

2994

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

6.6

323.0

911

1440

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

23.3

323.0

759

337

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

2878.8

323.0

580

WX110

NOMESCO Finland

Local anesthesy

1.8

323.0

14521

116737

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.8

323.0

3457

10494

C10AA01

ATC

simvastatin; oral

2.1

323.0

7464

44422

A10BB12

ATC

glimepiride; oral

5.2

323.0

1837

3821

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

323.0

8739

53658

C07AB07

ATC

bisoprolol; oral

2.3

323.0

9132

53850

H02AB06

ATC

prednisolone; systemic

1.9

323.0

9690

64625

A02BC02

ATC

pantoprazole; systemic

2.1

323.0

13335

97491

J01FF01

ATC

clindamycin; systemic

2.1

323.0

6057

34287

160

Kela drug reimbursment

exenatide

21.7

323.0

1379

680

J45.9

ICD-10 Finland

Asthma, unspecified

2.7

323.0

4430

19052

E66

ICD-10 Finland

Obesity

15.2

323.0

2903

2202

B01AB05

ATC

enoxaparin; parenteral

2.4

323.0

6789

35187

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.6

323.0

2722

11196

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

323.0

3572

16328

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

6.9

323.0

921

1382

C03CA01

ATC

furosemide; systemic

4.1

323.0

6662

21599

M04AA01

ATC

allopurinol; systemic

3.7

323.0

2915

8812

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.2

323.0

2616

8830

SPAT1263

SPAT

Sampling

2.0

323.0

9433

61353

E66.0

ICD-10 Finland

Obesity due to excess calories

589.5

323.0

1483

QBJ30

NOMESCO Finland

Correction of abdominal apron

42.1

323.0

675

166

A10BK03

ATC

empagliflozin; oral

5.5

323.0

2519

5111

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.3

323.0

3984

19293

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

323.0

7908

52292

N02BE01

ATC

paracetamol; systemic, rectal

3.0

323.0

18184

148362

R03AC02

ATC

salbutamol; inhalant

2.2

323.0

11990

79813

A10BX07

ATC

[U] liraglutide; parenteral

22.5

323.0

844

390

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

7.6

323.0

1677

2382

A10AE04

ATC

insulin glargine; parenteral

4.4

323.0

2948

7612

SPAT1262

SPAT

Handing over of treatment supplies

4.0

323.0

5566

17607

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

13.0

323.0

2964

2627

XG466

NOMESCO Finland

Sleep oxymetry

5.9

323.0

1110

1955

SPAT1148

SPAT

Treatment of chronic ulcer or burn

3.0

323.0

3012

11304

162

Kela drug reimbursment

liraglutide

20.3

323.0

711

362

I10

ICD-10 Finland

Essential (primary) hypertension

3.5

323.0

12807

66663

C08CA01

ATC

amlodipine; oral

2.3

323.0

6820

36386

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.7

323.0

2118

6186

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

323.0

9769

66709

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.7

323.0

3119

12573

C03DA01

ATC

spironolactone; oral

3.4

323.0

2416

7822

J01DB01

ATC

cefalexin; oral

2.4

323.0

17323

143201

A10BJ02

ATC

liraglutide; parenteral

16.1

323.0

1430

952

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

3.1

323.0

6593

27102

SPAT1310

SPAT

Counselling related to known health issue

1.9

323.0

6857

42796

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

4.2

323.0

4575

13056

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

9.3

323.0

2757

3385

A10BH01

ATC

sitagliptin; oral

5.4

323.0

3128

6605

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.7

323.0

2047

6015

SPAT1249

SPAT

Treatment-related counselling outside office

1.9

323.0

8679

58191

A10BK01

ATC

dapagliflozin; oral

5.1

323.0

1449

3022

A10BJ06

ATC

semaglutide; parenteral

11.3

323.0

1764

1687

A10AE05

ATC

insulin detemir; parenteral

3.7

323.0

1555

4397

E66.9

ICD-10 Finland

Obesity, unspecified

105.2

323.0

3076

344

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

5.8

323.0

3009

5920

R4190

NOMESCO Finland

Nutritional therapy

5.7

323.0

1272

2356

103

Kela drug reimbursment

Diabetes, insulin-treated

5.0

323.0

8380

24947

T82

ICPC

Obesity

15.9

323.0

2704

1943

I50.9

ICD-10 Finland

Heart failure, unspecified

3.8

323.0

2448

7034

RD210

NOMESCO Finland

8.1

323.0

799

1015

N03AX16

ATC

pregabalin; oral

2.1

323.0

5087

27355

A10BA02

ATC

metformin; oral

6.5

323.0

9817

25455

E66.8

ICD-10 Finland

Other obesity

170.7

323.0

5575

448

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

323.0

5959

34651

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3554.5

323.0

1997

R06.0

ICD-10 Finland

Dyspnoea

2.6

323.0

5708

26512

205

Kela drug reimbursment

Chronic hypertension

3.0

323.0

5854

23959

A08AB01

ATC

orlistat; oral

25.1

322.5

462

188

N06AB04

ATC

citalopram; systemic

2.1

320.9

4703

25888

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

320.3

5913

35602

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

313.8

4143

21795

C03AA03

ATC

hydrochlorothiazide; oral

3.0

313.7

1959

6863

R60.0

ICD-10 Finland

Localized oedema

2.7

313.1

2329

9131

N05AH04

ATC

quetiapine; oral

2.2

312.5

3826

19464

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

309.1

296

C10AA05

ATC

atorvastatin; oral

1.9

305.5

6513

41130

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

6.3

304.8

857

1409

A10BH05

ATC

linagliptin; oral

4.7

304.8

1117

2500

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

302.5

6545

41508

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.5

302.0

2695

11709

N06AX21

ATC

duloxetine; oral

2.5

300.7

2644

11395

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.3

297.8

3050

14223

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.5

297.6

2562

10909

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.6

296.0

2460

10269

A10BG03

ATC

pioglitazone; oral

6.6

292.9

799

1261

M10.9

ICD-10 Finland

Gout, unspecified

3.7

292.2

1383

3921

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

+∞

291.3

279

R06.5

ICD-10 Finland

Mouth breathing

2.8

290.5

2127

8236

J01AA02

ATC

doxycycline; systemic

1.8

288.4

15440

128877

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

288.0

4016

21516

A10BJ01

ATC

exenatide; parenteral

16.0

286.1

478

306

J01DA01

ATC

[U] cefalexin; systemic

1.7

284.8

12645

99430

C09AA05

ATC

ramipril; oral

2.0

281.7

4150

22714

L15

ICPC

Knee symptom/complaint

2.0

281.5

4211

23190

S18

ICPC

Laceration/cut

1.7

280.2

7929

54480

I50.0

ICD-10 Finland

Congestive heart failure

4.0

280.2

1205

3141

K02.1

ICD-10 Finland

Caries of dentine

1.7

278.1

12028

93519

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.8

277.1

1960

7417

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.3

274.1

2911

13772

WX290

NOMESCO Finland

Other blockade of nerve

1.7

273.9

9706

71126

C08CA13

ATC

lercanidipine; oral

2.5

272.2

2443

10604

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.6

272.2

2166

8795

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.2

272.1

3298

16586

L28

ICPC

Limited function/disability (L)

2.3

271.9

2830

13251

C09CA01

ATC

losartan; oral

2.0

271.0

4307

24239

B01AA03

ATC

warfarin; systemic

2.2

270.6

3080

15048

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.6

270.5

2197

9024

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

269.8

8481

59923

SPAT1254

SPAT

Administration of medicine

2.3

267.8

2954

14216

N06AB03

ATC

fluoxetine; oral

2.3

267.0

2907

13900

A10BD07

ATC

metformin and sitagliptin; systemic

4.1

266.9

1126

2881

L03

ICPC

Low back symptom/complaint

1.9

266.8

5024

30083

L17

ICPC

Foot/toe symptom/complaint

1.9

265.6

4970

29682

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

263.3

3959

21767

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

4.3

262.9

1035

2481

H03AA01

ATC

levothyroxine sodium; systemic

1.9

260.9

4790

28383

S97

ICPC

Chronic ulcer skin

3.7

260.4

1215

3395

R02

ICPC

Shortness of breath/dyspnoea

2.4

260.0

2530

11435

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.6

257.3

948

2127

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.7

256.0

11390

88256

C02AC05

ATC

moxonidine; oral

4.1

246.2

1043

2675

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.1

244.4

3435

18314

R03BA05

ATC

fluticasone; inhalant

2.0

244.0

3877

21694

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

243.6

7321

50588

N03AX12

ATC

gabapentin; oral

2.1

240.9

3186

16551

J01MA12

ATC

levofloxacin; systemic

2.0

240.8

3507

18955

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.8

240.8

5528

35162

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.7

240.4

7938

56282

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

5.5

239.5

751

1410

SPAT1301

SPAT

No procedures

1.7

238.8

6182

40800

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

238.2

2354

10692

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.6

234.5

1874

7592

N06AX12

ATC

bupropion; oral

2.8

234.4

1675

6350

C07AB02

ATC

metoprolol; systemic

2.0

231.0

3376

18238

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

230.3

4319

25605

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.2

230.0

2629

12784

SPAT1312

SPAT

General health counselling

1.7

227.7

6627

45130

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

226.5

2722

13534

B03BA03

ATC

hydroxocobalamin; parenteral

3.4

222.7

1150

3478

WX780

NOMESCO Finland

Remote monitoring CPAP

3.7

222.1

1033

2870

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

6.2

222.0

628

1037

EBA00

NOMESCO Finland

Extraction of tooth

1.7

221.0

6668

45784

C09BA02

ATC

enalapril and diuretics; systemic

2.8

220.3

1561

5878

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

219.7

3433

18995

R03BB04

ATC

tiotropium bromide; inhalant

2.6

219.7

1807

7429

SPAT1240

SPAT

Therapeutic discussion

2.2

219.4

2650

13188

E66.1

ICD-10 Finland

Drug-induced obesity

114.7

218.6

238

XCK10

NOMESCO Finland

Photography of fundus of eye

2.4

217.6

1987

8640

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.4

216.0

2097

9410

C09DA01

ATC

losartan and diuretics; oral

2.4

215.9

1992

8708

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

215.5

1711

6890

T83

ICPC

Overweight

5.8

214.4

643

1143

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

214.0

10346

80206

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

213.2

6082

40996

SGA01

NOMESCO Finland

Tooth opening as first aid

1.9

211.7

3575

20333

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

211.6

9896

76000

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.3

211.0

2277

10750

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.5

208.6

1047

3093

WX723

NOMESCO Finland

CPAP therapy

3.8

207.6

940

2551

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

205.7

9184

69523

N05BA04

ATC

oxazepam; oral

1.7

204.4

4824

30653

M25.5

ICD-10 Finland

Pain in joint

1.7

202.2

5700

38163

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

202.0

4738

30029

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.1

200.4

2435

12115

M01AB05

ATC

diclofenac; systemic, rectal

1.6

200.4

13023

107719

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

200.2

3346

18914

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.5

199.8

746

1691

M01AH05

ATC

etoricoxib; oral

1.6

199.2

11467

92035

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.4

198.3

1928

8638

A10BJ05

ATC

dulaglutide; parenteral

12.0

196.4

371

315

SPAT1260

SPAT

Consultation of another employee

1.9

196.3

3514

20346

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

196.2

10752

85141

207

Kela drug reimbursment

Chronic arrhythmias

2.2

195.9

2156

10252

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

9.0

194.9

429

487

P01AB01

ATC

metronidazole; oral, rectal

1.6

193.9

7830

57524

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

192.7

3307

18847

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

192.7

11646

94197

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.2

192.2

2142

10236

ACC51

NOMESCO Finland

Release of median nerve

2.5

191.3

1620

6746

M01AE02

ATC

naproxen; oral, rectal

1.5

190.7

11296

90821

R05FB02

ATC

cough suppressants and expectorants

1.6

189.4

6830

48675

J01FA06

ATC

roxithromycin; oral

1.6

189.3

7728

56822

J45.1

ICD-10 Finland

Nonallergic asthma

2.6

187.5

1502

6061

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

187.2

3892

23654

358

Kela drug reimbursment

liraglutide

18.7

186.5

293

159

N06AB10

ATC

escitalopram; oral

1.7

184.9

4278

26884

SPAT1211

SPAT

Application of soft bandage

2.3

184.2

1856

8449

J01CE02

ATC

phenoxymethylpenicillin; oral

1.6

183.0

13994

118850

C01DA14

ATC

isosorbide mononitrate; oral

2.2

183.0

1969

9247

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

182.2

2288

11512

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.6

181.7

7832

58175

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

180.3

14283

122064

A02BC01

ATC

omeprazole; systemic

1.7

178.7

4967

32891

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

6.5

178.7

486

761

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.6

178.3

1419

5700

J96.1

ICD-10 Finland

Chronic respiratory failure

6.5

178.3

487

767

SPAT1229

SPAT

Assessment of need for aid

2.6

178.2

1441

5839

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.6

178.1

1456

5937

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.7

178.1

5044

33574

C09CA06

ATC

candesartan; oral

1.8

177.2

3923

24270

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

177.1

4731

30960

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

176.9

1429

5786

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.8

176.3

3855

23749

SPAT1139

SPAT

Nutrition survey

3.8

175.7

805

2202

R03BA02

ATC

budesonide; inhalant

1.8

175.5

3481

20780

SPAT1153

SPAT

Removal of sutures

1.6

175.3

5738

39687

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

174.7

1905

8989

N02AA05

ATC

oxycodone; systemic

2.0

174.5

2369

12300

K04.0

ICD-10 Finland

Pulpitis

2.1

174.5

2243

11386

S76

ICPC

Skin infection other

3.0

174.3

1102

3841

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.9

172.4

1110

3914

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

172.4

6827

49496

P76

ICPC

Depressive disorder

2.4

170.6

1523

6508

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

170.3

2143

10773

M03BX02

ATC

tizanidine; oral

1.5

170.0

12238

101513

A08AA10

ATC

sibutramine; oral

25.6

169.8

241

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

168.6

4816

32042

J45

ICD-10 Finland

Asthma

2.1

168.3

2008

9861

C09CA03

ATC

valsartan; oral

2.4

167.7

1606

7113

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.7

167.2

1202

4543

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

166.8

2473

13277

R03DC03

ATC

montelukast; oral

1.8

166.5

3257

19311

P06

ICPC

Sleep disturbance

2.1

165.5

2077

10421

N06AB06

ATC

sertraline; oral

2.0

164.7

2354

12456

M10

ICD-10 Finland

Gout

3.4

164.5

851

2567

M48.0

ICD-10 Finland

Spinal stenosis

2.2

164.4

1952

9561

SPAT1216

SPAT

Assessment of functional ability

2.0

164.4

2470

13327

N05CF01

ATC

zopiclone; oral

1.6

163.8

5499

38139

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.2

163.6

1841

8804

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

163.6

4546

29973

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.5

163.2

1428

6032

A10BB01

ATC

glibenclamide; oral

4.4

162.4

626

1462

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.1

162.4

956

3170

N06AA09

ATC

amitriptyline; systemic

2.2

162.3

1891

9182

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.3

161.9

1610

7257

A08

ICPC

Swelling

3.4

161.9

847

2577

R06AE07

ATC

cetirizine; oral

1.5

161.4

8602

66489

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

6.0

161.3

469

801

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

160.3

1791

8530

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

5.2

159.7

520

1017

J01CA04

ATC

amoxicillin; systemic

1.6

159.4

16212

144276

C09DA06

ATC

candesartan and diuretics; oral

2.5

158.9

1372

5752

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

158.1

3256

19597

N06AX11

ATC

mirtazapine; oral

1.6

155.7

5866

41758

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

155.6

2409

13125

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

8.3

155.4

357

435

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

3.1

155.3

923

3079

A08AA02

ATC

fenfluramine; oral (centrally acting antiobesity products)

8.8

154.3

342

393

A28

ICPC

Limited function/disability NOS

2.0

153.2

2050

10543

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

153.1

2205

11679

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

153.0

2474

13688

P03

ICPC

Feeling depressed

2.0

152.0

2066

10690

R96

ICPC

Asthma

2.2

151.6

1704

8130

C10AA07

ATC

rosuvastatin; oral

1.7

151.6

3943

25432

L16

ICPC

Ankle symptom/complaint

2.1

151.2

1994

10192

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

151.1

2833

16507

B81

ICPC

Anaemia vit B12/folate deficiency

3.6

150.0

734

2117

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

149.8

2501

13992

SPAT1255

SPAT

Intravenous administration of medicine

2.5

149.2

1300

5470

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

149.1

3707

23584

N05AX12

ATC

aripiprazole; systemic

2.9

149.1

963

3397

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

6.3

148.6

414

669

I50

ICD-10 Finland

Heart failure

4.8

148.4

519

1098

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

147.3

2772

16161

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

147.3

4186

27643

W85

ICPC

Gestational diabetes

2.9

147.3

984

3547

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

147.2

1464

6590

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

145.6

4964

34360

C08CA02

ATC

felodipine; oral

2.3

144.7

1441

6487

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.6

144.2

692

1964

W84

ICPC

Pregnancy high risk

3.0

143.9

897

3089

J20

ICD-10 Finland

Acute bronchitis

2.1

143.8

1857

9400

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

142.2

4808

33171

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.7

141.8

1030

3905

K07

ICPC

Swollen ankles/oedema

3.3

141.8

768

2395

A06AD11

ATC

lactulose; oral

2.0

141.0

2143

11564

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.2

141.0

1560

7378

S10

ICPC

Boil/carbuncle

2.6

140.9

1142

4615

A10BX01

ATC

guar gum; systemic

3.6

140.6

686

1974

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.5

140.4

701

2054

M02AA07

ATC

piroxicam; topical

1.5

139.7

6197

45557

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

3.0

139.5

875

3024

M79.7

ICD-10 Finland

Fibromyalgia

3.1

138.7

829

2773

UJF32

NOMESCO Finland

Coloscopy

1.6

138.6

4312

29094

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.0

138.5

2077

11149

SPAT1283

SPAT

Restricted health certificate

1.6

137.6

3986

26386

J01MA02

ATC

ciprofloxacin; systemic

1.5

137.3

6665

49933

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.8

136.0

2485

14311

R53

ICD-10 Finland

Malaise and fatigue

1.7

135.7

3624

23453

SPAT1097

SPAT

Recording of ECG

1.8

135.6

2482

14299

M10.0

ICD-10 Finland

Idiopathic gout

3.8

135.1

612

1655

A10BG02

ATC

rosiglitazone; oral

6.5

134.9

366

571

R51.80

ICD-10 Finland

Headache

1.7

134.9

2968

18148

177

Kela drug reimbursment

Insulin glargine 300 U / ml

4.2

134.8

540

1308

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

134.8

2065

11167

R01AD09

ATC

mometasone; nasal

1.4

134.7

8821

70211

J46

ICD-10 Finland

Status asthmaticus

3.6

134.7

649

1848

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

134.5

1977

10522

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2.6

134.1

1046

4134

R03AC03

ATC

terbutaline; inhalant

1.8

134.1

2685

15933

WZA90

NOMESCO Finland

Other doctors statement

1.6

132.8

4413

30230

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

132.3

922

3408

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.8

131.5

594

1603

B01AF02

ATC

apixaban; oral

2.2

131.4

1409

6560

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.5

130.7

1147

4837

JN3AD

NOMESCO Finland

Abdominal CT examination

2.2

130.1

1401

6536

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

129.9

1385

6432

A10BH02

ATC

vildagliptin; oral

4.7

129.4

459

985

N03AX09

ATC

lamotrigine; oral

2.5

129.3

1119

4682

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.9

129.3

2290

13032

J01FA09

ATC

clarithromycin; systemic

1.5

127.9

6047

44870

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

127.9

7314

56465

A10BD03

ATC

metformin and rosiglitazone; systemic

6.0

127.9

371

632

H02AB04

ATC

methylprednisolone; systemic

1.8

127.5

2635

15772

C07AG02

ATC

carvedilol; oral

2.6

126.5

982

3869

T07

ICPC

Weight gain

6.1

126.4

360

599

C09DA03

ATC

valsartan and diuretics; oral

2.8

125.3

888

3313

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

4.3

125.3

494

1179

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

124.8

1359

6367

A02BC05

ATC

esomeprazole; systemic

1.5

124.8

7193

55540

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.6

124.4

452

995

L90

ICPC

Osteoarthrosis of knee

2.5

123.8

1066

4444

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.2

123.8

1352

6345

C01AA05

ATC

digoxin; systemic

2.6

123.7

943

3675

AN1

Coronary angiography

2.0

123.6

1683

8677

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

123.4

912

3491

R06.2

ICD-10 Finland

Wheezing

2.7

123.2

918

3529

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

4.4

123.1

473

1101

R05

ICPC

Cough

1.6

121.9

4083

27930

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

3.2

121.7

675

2141

D07AC01

ATC

betamethasone; topical

1.5

121.5

6023

45029

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.0

121.3

1743

9179

B01AF01

ATC

rivaroxaban; oral

1.9

121.1

1825

9785

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.8

120.8

2197

12597

R03BA01

ATC

beclometasone; inhalant

1.8

120.4

2544

15313

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

120.2

2877

17977

H02AB07

ATC

prednisone; oral

1.8

119.5

2486

14889

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

119.4

1174

5237

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

119.2

2285

13329

M01AX05

ATC

glucosamine; oral

1.7

118.7

2918

18368

N18.8

ICD-10 Finland

Other chronic renal failure

3.8

117.1

528

1422

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.3

117.1

1159

5188

H3600, E113

ICD-10 Finland

6.4

116.7

319

503

WZC30

NOMESCO Finland

Teaching

1.8

116.4

2337

13830

N05AA02

ATC

levomepromazine; systemic

2.7

115.9

841

3183

J01CE08

ATC

benzathine benzylpenicillin; parenteral

7.0

115.2

295

425

XX_20

NOMESCO Finland

Bioimpedance measurement

55.1

114.7

137

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.3

114.2

1187

5438

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.2

113.6

1304

6250

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.2

113.5

638

2042

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.9

113.5

1928

10785

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.8

113.2

756

2717

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.9

112.8

384

789

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

112.2

2289

13602

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

111.2

1636

8680

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.0

110.3

1613

8534

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

110.2

2570

15899

SPAT1058

SPAT

PEF monitoring instruction

2.0

110.2

1502

7734

F34.1

ICD-10 Finland

Dysthymia

2.7

110.0

803

3049

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

109.9

5007

36604

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

9.5

109.5

232

247

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

109.2

3967

27560

M54

ICD-10 Finland

Dorsalgia

1.8

109.2

2126

12439

A12BA01

ATC

potassium chloride; oral

3.2

108.9

612

1959

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.0

108.2

1415

7160

SPAT1234

SPAT

Support of social functional capacity

2.6

108.0

833

3265

SPAT1104

SPAT

Monitoring of emergency patient

2.2

107.7

1191

5607

M01AX17

ATC

nimesulide; oral

1.5

107.7

3968

27644

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

106.7

3019

19698

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.5

106.7

882

3592

N05CD07

ATC

temazepam; oral

1.9

106.7

1803

10056

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

105.9

1442

7414

K08.3

ICD-10 Finland

Retained dental root

2.2

105.9

1214

5811

WX320

NOMESCO Finland

Spinalanesthesy

1.5

105.8

3846

26697

S80.0

ICD-10 Finland

Contusion of knee

2.1

105.4

1273

6232

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.9

105.4

1627

8779

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.0

104.8

1548

8218

R32

ICD-10 Finland

Unspecified urinary incontinence

3.4

104.4

542

1635

R03DA04

ATC

theophylline; systemic, rectal

2.7

104.3

782

3016

XG410

NOMESCO Finland

Flow-volume spirometry

2.6

104.2

799

3118

H3601, E113

ICD-10 Finland

5.2

104.0

338

660

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

103.9

12685

110678

A02BC03

ATC

lansoprazole; oral

1.5

103.8

4837

35447

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

3.6

103.7

499

1418

SPAT1281

SPAT

Other administrative function

2.0

103.4

1525

8087

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

102.7

1761

9862

N62

ICD-10 Finland

Hypertrophy of breast

2.5

102.7

874

3616

A01

ICPC

Pain general/multiple sites

2.0

102.4

1350

6853

K04.1

ICD-10 Finland

Necrosis of pulp

1.8

102.0

2004

11745

AA1AD

NOMESCO Finland

CT of head and brain

1.6

101.7

3561

24468

A03

ICPC

Fever

1.6

101.2

3094

20564

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

101.0

5186

38728

E0000UV

ATC

1.4

100.8

7135

56599

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.9

100.5

638

2218

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

99.7

679

2470

J01FA10

ATC

azithromycin; systemic

1.4

99.7

11300

97017

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

99.6

1479

7861

I50.1

ICD-10 Finland

Left ventricular failure

2.9

99.1

634

2216

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.6

99.0

767

3012

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

6.1

98.9

282

471

R42

ICD-10 Finland

Dizziness and giddiness

1.6

98.8

3387

23141

N05AX08

ATC

risperidone; systemic

2.1

98.5

1253

6262

D07AC13

ATC

mometasone; topical

1.4

98.4

5116

38259

SPAT1377

SPAT

Polysomnography

2.7

98.0

709

2675

A10BX09

ATC

[U] dapagliflozin; oral

6.1

97.8

276

455

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

97.4

3036

20258

K04.08

ICD-10 Finland

Other specified pulpit

2.0

97.4

1345

6949

D11

ICPC

Diarrhoea

1.7

97.3

2145

13013

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.8

96.3

1865

10866

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.1

96.3

1131

5464

XF402

NOMESCO Finland

ECG with work load test

1.8

96.2

1742

9930

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

96.0

4950

36923

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.5

95.8

791

3216

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

94.7

926

4111

M01AB01

ATC

indometacin; systemic, rectal

2.1

94.7

1159

5700

L08

ICPC

Shoulder symptom/complaint

1.6

94.7

3134

21209

N05BA01

ATC

diazepam; systemic, rectal

1.7

94.6

2224

13745

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.7

94.6

672

2507

L14

ICPC

Leg/thigh symptom/complaint

2.0

94.3

1237

6256

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.4

93.7

257

408

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.5

93.6

3532

24634

L86

ICPC

Back syndrome with radiating pain

2.2

93.2

1026

4817

Z71.8

ICD-10 Finland

Other specified counselling

1.5

93.0

4379

32034

D01AC02

ATC

miconazole; topical

2.0

92.8

1300

6751

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.9

92.5

1393

7434

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

92.0

2470

15833

R74

ICPC

Upper respiratory infection acute

1.4

91.9

5585

42915

R50.9

ICD-10 Finland

Fever, unspecified

1.6

90.3

2376

15142

TFP20

NOMESCO Finland

Cardiodefibrillation

2.1

90.0

1067

5173

E000001

ATC

1.5

89.9

3691

26204

C10AX09

ATC

ezetimibe; oral

1.8

89.6

1663

9544

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.0

89.6

550

1871

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

5.0

88.5

295

593

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

88.4

610

2234

J01CF05

ATC

flucloxacillin; systemic

2.5

88.3

721

2913

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

88.1

3690

26291

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

88.1

7898

64750

S29

ICPC

Skin symptom/complaint other

1.6

87.7

2751

18337

R01AD08

ATC

fluticasone; nasal

1.4

87.5

5242

40098

N19

ICD-10 Finland

Unspecified kidney failure

3.2

87.3

489

1561

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

86.6

3823

27531

WX002

NOMESCO Finland

Sedation and analgesia

1.5

86.6

3158

21812

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

86.3

2432

15772

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.0

86.1

1241

6507

J45.8

ICD-10 Finland

Mixed asthma

2.8

86.0

587

2136

L60.0

ICD-10 Finland

Ingrowing nail

2.4

86.0

798

3450

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

85.9

1290

6869

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

85.7

5190

39740

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.2

85.7

959

4532

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

4.0

85.5

360

914

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

85.3

1564

8935

AA40B

NOMESCO Finland

9.2

84.8

182

199

SPAT1054

SPAT

Examination of peripheral nervous system

3.9

84.6

366

952

M01AC06

ATC

meloxicam; systemic, rectal

1.4

84.5

6199

49070

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.3

84.2

825

3664

SPAT1059

SPAT

Spirometry at the office

2.2

84.1

915

4268

B01AB04

ATC

dalteparin; parenteral

2.3

83.8

825

3671

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

83.7

1567

9012

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.2

82.8

856

3901

C10AB05

ATC

fenofibrate; oral

3.8

82.8

370

990

N06AX03

ATC

mianserin; oral

2.3

82.7

842

3808

JDF21

NOMESCO Finland

Laparoscopic gastric banding

+∞

82.3

K78

ICPC

Atrial fibrillation/flutter

2.1

82.3

969

4678

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.9

82.1

1239

6608

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

82.0

2044

12811

F32.1

ICD-10 Finland

Moderate depressive episode

2.0

81.9

1119

5745

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.1

81.6

480

1586

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

81.5

1623

9517

4019X

ICD-9 Finland

Essential hypertension, Unspecified

3.7

81.3

374

1025

SPAT1325

SPAT

Vaccination

1.4

81.2

5468

42581

M01AH02

ATC

rofecoxib; oral

1.7

81.2

1996

12459

A02BA02

ATC

ranitidine; systemic

1.5

81.1

2987

20647

SPAT1307

SPAT

Psychosocial counselling and guidance

1.9

81.1

1284

6969

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.6

81.0

643

2560

G04BD12

ATC

mirabegron; oral

1.8

80.7

1437

8124

R03AC13

ATC

formoterol; inhalant

2.2

80.7

853

3924

J01MA14

ATC

moxifloxacin; systemic

1.8

80.4

1457

8285

M79.1

ICD-10 Finland

Myalgia

1.6

80.4

2300

14953

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

4.7

80.2

287

623

SPAT1094

SPAT

Continuous Positive Airway Pressure

4.6

79.9

290

639

D07XC01

ATC

betamethasone, combinations; topical

1.7

79.8

1941

12077

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

79.6

1229

6606

F61.0

ICD-10 Finland

Mixed personality disorders

3.3

79.6

431

1343

F32

ICD-10 Finland

Depressive episode

2.0

79.6

1050

5317

M02AA10

ATC

ketoprofen; topical

1.6

79.5

2544

17004

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.5

79.3

680

2821

SPAT1051

SPAT

Guidance regarding sleep disorders

3.6

79.3

376

1057

O80.8

ICD-10 Finland

Other single spontaneous delivery

2.2

79.3

900

4275

A04

ICPC

Weakness/tiredness general

1.6

79.3

2106

13424

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.9

79.2

231

398

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.7

79.1

361

983

RD112

NOMESCO Finland

13.4

78.9

140

105

R04

ICPC

Breathing problem other

2.5

78.7

648

2630

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

78.4

3117

21894

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.3

78.4

780

3487

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.2

78.3

842

3904

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

78.1

5863

46438

A10BX02

ATC

repaglinide; oral

4.9

77.9

265

546

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.2

77.8

808

3687

B01AB10

ATC

tinzaparin; parenteral

2.0

77.8

1132

5952

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

77.7

2045

12994

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.0

77.6

1131

5951

H01

ICPC

Ear pain/earache

1.7

77.5

1936

12126

A10AE06

ATC

insulin degludec; parenteral

2.6

77.5

600

2354

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

77.4

4793

36718

EBA30

NOMESCO Finland

Excision of root of tooth

2.2

77.2

879

4183

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.4

77.1

706

3032

QBJ05

NOMESCO Finland

Other correction of loose or redundant skin of trunk

57.1

76.9

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.9

76.8

505

1794

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

76.8

1911

11957

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

76.3

1710

10381

B01AC04

ATC

clopidogrel; oral

1.6

76.1

1955

12337

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.7

76.0

1630

9771

N05AF03

ATC

chlorprothixene; systemic

2.7

75.6

550

2080

L73.2

ICD-10 Finland

Hidradenitis suppurativa

4.4

75.6

288

666

P29

ICPC

Psychological sympt/compl other

1.9

75.6

1121

5935

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

75.0

1439

8328

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

74.9

4117

30834

N03AG01

ATC

valproic acid; systemic, rectal

1.9

74.8

1101

5813

XA420

NOMESCO Finland

Extensive sleep examination

4.4

74.5

282

648

C09CA07

ATC

telmisartan; oral

1.9

74.5

1109

5881

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.8

74.4

510

1861

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.1

74.4

927

4581

P99

ICPC

Psychological disorders other

2.6

74.3

586

2321

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

74.1

713

3135

SPAT1252

SPAT

Overall medication plan or its review

2.0

73.8

1023

5279

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.6

73.8

346

964

UKC02

NOMESCO Finland

Cystoscopy

1.6

73.8

2192

14362

N05BA12

ATC

alprazolam; oral

1.7

73.7

1731

10648

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.0

73.4

446

1507

G44.2

ICD-10 Finland

Tension-type headache

1.6

73.4

2383

15962

C07BB07

ATC

bisoprolol and thiazides; systemic

2.4

73.3

642

2694

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.8

73.3

492

1774

R03AC12

ATC

salmeterol; inhalant

2.3

73.3

716

3173

R11

ICD-10 Finland

Nausea and vomiting

1.8

73.1

1329

7555

Z01.2

ICD-10 Finland

Dental examination

1.3

72.9

7630

63448

A41.9

ICD-10 Finland

Sepsis, unspecified

2.6

72.9

546

2103

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.4

72.8

677

2928

N06AX26

ATC

vortioxetine; oral

1.9

72.5

1062

5594

B02AA02

ATC

tranexamic acid; systemic

1.5

72.5

2658

18309

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

2.2

72.4

810

3824

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

72.3

1648

10052

NG2AA

NOMESCO Finland

Patella X-ray examination

2.9

72.3

474

1683

3051

Kela drug reimbursment

15.7

72.2

120

A10AB06

ATC

insulin glulisine; parenteral

4.6

72.2

262

578

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.3

72.1

379

1155

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.5

71.8

584

2354

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

71.4

1006

5221

C03BA11

ATC

indapamide; oral

2.9

71.4

465

1645

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.9

71.2

450

1561

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

71.2

1978

12736

R03AK08

ATC

formoterol and beclometasone; inhalant

2.3

71.2

696

3085

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.5

71.1

343

978

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.9

71.0

1141

6215

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.7

71.0

253

548

H66.9

ICD-10 Finland

Otitis media, unspecified

1.9

70.9

1071

5706

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

70.3

1096

5905

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.4

70.3

364

1098

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

3.0

70.0

431

1469

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

69.9

611

2562

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.6

69.8

2026

13188

JDF97

NOMESCO Finland

Other laparoscopic bariatric operation on stomach

+∞

69.8

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

69.6

2523

17316

L13

ICPC

Hip symptom/complaint

1.6

69.6

2284

15318

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

3.2

69.5

381

1198

D07AD01

ATC

clobetasol; topical

1.5

69.4

2539

17464

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

69.3

2922

20724

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.0

69.3

431

1479

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

69.2

1251

7098

N06AA12

ATC

doxepin; systemic

2.1

68.9

844

4143

I25.2

ICD-10 Finland

Old myocardial infarction

2.2

68.8

778

3689

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.1

68.8

815

3943

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.0

68.7

920

4682

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.7

68.7

1707

10658

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

68.7

871

4335

N05AN01

ATC

lithium; oral

2.6

68.2

518

2011

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

68.1

5334

42331

U04

ICPC

Incontinence urine

2.3

68.0

648

2837

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

67.9

809

3923

RD140

NOMESCO Finland

94.1

67.9

A99

ICPC

Disease/condition unspecnature/site

1.8

67.8

1248

7123

M09AX01

ATC

hyaluronic acid; parenteral

2.3

67.6

686

3095

R05

ICD-10 Finland

Cough

1.5

67.5

3119

22528

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

67.4

17725

167497

C02EA02

ATC

2.5

67.4

546

2195

L01

ICPC

Neck symptom/complaint

1.5

67.3

2334

15855

R29

ICPC

Respiratory symptom/complaint other

1.9

67.2

1088

5944

C09DA07

ATC

telmisartan and diuretics; oral

2.3

67.1

682

3079

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.5

66.9

2629

18356

KGH10

NOMESCO Finland

Operation for phimosis

2.9

66.8

422

1462

C09AA03

ATC

lisinopril; oral

2.2

66.8

686

3114

H25.8

ICD-10 Finland

Other senile cataract

1.8

66.8

1190

6717

N06AB05

ATC

paroxetine; oral

1.9

66.7

1122

6210

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.7

66.7

1561

9584

J02AC01

ATC

fluconazole; systemic

1.3

66.5

7476

62552

I48.2

ICD-10 Finland

Chronic atrial fibrillation

3.2

66.3

363

1141

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

15.3

66.2

111

R4110

NOMESCO Finland

Physiotherapy

1.4

66.2

4243

32549

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

66.2

1289

7489

P01

ICPC

Feeling anxious/nervous/tense

1.6

66.1

1993

13084

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.2

66.1

678

3075

R52.9

ICD-10 Finland

Pain, unspecified

1.7

66.1

1370

8115

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

65.8

1321

7746

C09BA03

ATC

lisinopril and diuretics; oral

3.1

65.4

377

1230

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

1.6

65.2

1839

11868

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

65.2

1117

6222

K85

ICPC

Elevated blood pressure

1.6

65.0

2015

13319

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.1

64.9

820

4073

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.9

64.4

418

1474

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.3

64.4

643

2880

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.9

64.3

418

1476

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.1

64.2

363

1168

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.9

64.1

411

1439

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

1.9

63.9

1062

5851

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.1

63.8

362

1168

R99

ICPC

Respiratory disease other

3.2

63.5

346

1084

Z50.1

ICD-10 Finland

Other physical therapy

2.0

63.5

881

4542

N30.0

ICD-10 Finland

Acute cystitis

1.5

63.5

2199

14917

N06AX05

ATC

trazodone; oral

2.6

63.3

494

1948

K86

ICPC

Hypertension uncomplicated

1.7

63.2

1533

9499

D05AX52

ATC

calcipotriol, combinations; topical

1.9

63.1

916

4806

A10BD20

ATC

metformin and empagliflozin; systemic

4.3

63.1

242

565

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

63.0

1798

11636

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

62.9

1005

5461

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.6

62.9

495

1962

F50.8

ICD-10 Finland

Other eating disorders

7.4

62.8

153

207

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.2

62.7

348

1105

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.1

62.6

707

3350

L30.4

ICD-10 Finland

Erythema intertrigo

4.0

62.5

258

645

C08DB01

ATC

diltiazem; oral

2.3

62.5

618

2753

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.5

62.5

523

2144

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

62.2

1421

8656

212

Kela drug reimbursment

Gout

3.6

62.1

297

842

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.3

62.1

610

2708

SGB20

NOMESCO Finland

Filling of root of tooth with 2 root channels

1.8

62.1

1138

6481

D82

ICPC

Teeth/gum disease

1.3

61.9

6319

52004

N05AB03

ATC

perphenazine; systemic, rectal

2.2

61.5

628

2842

SPAT1360

SPAT

Extensive global examination

1.8

61.5

1160

6668

G04BD08

ATC

solifenacin; oral

1.9

61.5

911

4818

OAB72

SPAT

8.2

61.3

140

171

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

61.2

795

3994

N04BC05

ATC

pramipexole; oral

1.8

60.9

1060

5932

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.9

60.8

891

4694

K04.09

ICD-10 Finland

Pulpit UNS

2.0

60.6

782

3919

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.9

60.6

879

4612

G04BD04

ATC

oxybutynin; oral, transdermal

2.1

60.5

740

3625

J96.0

ICD-10 Finland

Acute respiratory failure

4.6

60.2

218

481

E000003

ATC

2.0

60.0

798

4047

UJD02

NOMESCO Finland

Gastroscopy

2.1

59.2

733

3611

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

58.6

1686

10924

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

2.9

58.6

366

1261

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.7

58.6

411

1522

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

58.6

1139

6607

C10AA04

ATC

fluvastatin; oral

1.8

58.6

1061

6015

N05AH03

ATC

olanzapine; systemic

1.8

58.4

1045

5902

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.3

58.3

576

2565

K77

ICPC

Heart failure

3.7

58.1

261

703

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

3.8

58.1

255

674

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

58.0

2086

14250

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

58.0

1499

9443

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.5

57.9

466

1867

L68.0

ICD-10 Finland

Hirsutism

5.2

57.9

184

353

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

2.9

57.8

379

1345

JAH01

NOMESCO Finland

Laparoscopy

1.9

57.8

838

4395

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.2

57.7

594

2698

R01AD12

ATC

fluticasone furoate; nasal

1.3

57.6

5441

44175

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

57.5

842

4429

ZXA00

NOMESCO Finland

Right side

1.4

57.3

3964

30680

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.3

57.3

551

2425

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

57.2

629

2945

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.8

56.5

963

5348

SPAT1251

SPAT

Organisation of medication

2.3

56.5

553

2453

TQW80

NOMESCO Finland

Local dermatologic skincare

2.5

56.5

461

1864

N03AX11

ATC

topiramate; oral

2.3

56.3

524

2269

I20.09

ICD-10 Finland

Unstable angina

2.1

56.1

694

3420

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

56.0

2371

16771

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.2

55.9

605

2813

X58

ICD-10 Finland

Exposure to other specified factors

1.5

55.9

2270

15914

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

55.8

2104

14514

N97.0

ICD-10 Finland

Female infertility associated with anovulation

2.6

55.8

426

1660

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

55.8

961

5358

T92

ICPC

Gout

3.3

55.6

290

881

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.2

55.5

591

2724

TK800

NOMESCO Finland

Hemodialysis

2.8

55.5

380

1388

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

55.3

1473

9354

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.7

55.2

394

1474

L02

ICPC

Back symptom/complaint

1.6

55.0

1508

9643

-1

NOMESCO Finland

1.3

55.0

6058

50170

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

54.8

1662

10903

Z00.0

ICD-10 Finland

General medical examination

1.4

54.7

2928

21661

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.0

54.6

692

3443

A08AA01

ATC

phentermine; oral

7.8

54.6

129

167

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.7

54.5

378

1392

-50

ICPC

Medication/prescr/renewal

2.1

54.4

660

3222

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.5

54.2

431

1718

WX402

NOMESCO Finland

General anaesthesia

1.4

54.2

2799

20565

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

54.2

1570

10183

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.8

54.2

362

1301

RK320

NOMESCO Finland

4.9

54.1

182

372

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

54.1

3837

29781

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.6

54.0

1430

9060

NF1AA

NOMESCO Finland

Hip X-ray examination

1.7

54.0

1125

6661

XQ800

NOMESCO Finland

Prick test

1.6

54.0

1372

8598

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.5

53.8

456

1880

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

2.4

53.7

459

1902

A10BD08

ATC

metformin and vildagliptin; systemic

4.9

53.6

181

372

N05CF02

ATC

zolpidem; oral

1.4

53.6

2888

21384

L29

ICPC

Musculoskeletal sympt/complt other

1.7

53.5

1159

6946

J01FA01

ATC

erythromycin; systemic

1.4

53.3

2538

18364

R21

ICPC

Throat symptom/complaint

1.4

53.1

3659

28249

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.6

53.0

409

1603

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

4.8

53.0

184

389

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.0

52.9

324

1101

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

52.8

3086

23179

R04.0

ICD-10 Finland

Epistaxis

1.8

52.6

952

5392

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.9

52.1

323

1109

F50.3

ICD-10 Finland

Atypical bulimia nervosa

5.4

52.0

161

300

L12

ICPC

Hand/finger symptom/complaint

1.5

51.9

2270

16141

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.1

51.9

628

3062

N01

ICPC

Headache

1.5

51.9

1826

12395

M76.6

ICD-10 Finland

Achilles tendinitis

1.9

51.8

745

3892

SFC92

NOMESCO Finland

Other demanding adjuvant procedure of filling therapy

1.7

51.8

1038

6074

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.3

51.7

501

2210

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.6

51.7

400

1571

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

51.6

660

3295

R03BA08

ATC

ciclesonide; inhalant

1.6

51.5

1346

8496

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.3

51.4

270

825

M15

ICD-10 Finland

Polyarthrosis

2.1

51.3

644

3190

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.1

51.0

639

3163

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.3

50.9

509

2281

D10

ICPC

Vomiting

1.7

50.6

1070

6361

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.5

50.6

186

418

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

50.5

587

2815

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.8

50.5

879

4914

O61.0

ICD-10 Finland

Failed medical induction of labour

3.6

50.5

239

674

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

50.4

2515

18339

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

50.4

1284

8050

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

50.4

861

4784

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.9

50.4

323

1134

C07AB03

ATC

atenolol; systemic

2.0

50.3

712

3696

D07AA02

ATC

hydrocortisone; topical

1.4

50.1

2274

16284

ZXA05

NOMESCO Finland

Left side

1.3

49.9

3665

28551

D02AE01

ATC

carbamide; topical

1.7

49.9

1091

6552

XF640

NOMESCO Finland

2.5

49.9

416

1702

S06

ICPC

Rash localized

1.8

49.8

834

4604

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.7

49.7

344

1265

A08AA04

ATC

dexfenfluramine; oral

12.0

49.6

R52.2

ICD-10 Finland

Other chronic pain

2.2

49.6

552

2600

SPAT1202

SPAT

Intra-articular injection

2.3

49.2

484

2151

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

49.2

1119

6796

N06AG02

ATC

moclobemide; oral

1.9

49.0

710

3720

C07FB02

ATC

metoprolol and felodipine; systemic

2.5

49.0

394

1582

SPAT1285

SPAT

Provision of consultation response

1.8

49.0

838

4660

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.0

49.0

299

1017

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

48.9

983

5753

J01FA15

ATC

telithromycin; oral

1.5

48.9

1684

11371

SGB30

NOMESCO Finland

Other demanding filling of root channel of tooth

1.5

48.9

2033

14300

C08CA10

ATC

nilvadipine; oral

2.9

48.8

304

1047

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.4

48.8

182

415

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.7

48.7

340

1258

R07.3

ICD-10 Finland

Other chest pain

1.6

48.7

1364

8760

K80.8

ICD-10 Finland

Other cholelithiasis

3.0

48.7

297

1009

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

3.0

48.6

286

947

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.8

48.5

331

1209

ULC02

NOMESCO Finland

Hysteroscopy

1.8

48.4

856

4812

R05DA01

ATC

ethylmorphine; oral

1.6

48.4

1247

7839

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

8.7

48.3

106

122

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.1

48.3

547

2592

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.2

48.3

528

2468

A10BB07

ATC

glipizide; oral

4.7

48.3

170

366

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.5

48.2

1574

10500

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.6

48.1

614

10637

C08CA05

ATC

nifedipine; systemic

1.8

48.1

865

4888

D01AC03

ATC

econazole; topical

1.8

48.0

909

5222

104

Kela drug reimbursment

Thyroid insufficiency

1.7

48.0

1059

6377

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

48.0

2148

15330

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

47.9

810

4484

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

47.9

418

1750

R78

ICPC

Acute bronchitis/bronchiolitis

2.5

47.8

377

1497

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

47.7

875

4977

M01AC01

ATC

piroxicam; systemic, rectal

1.5

47.7

1956

13712

S21

ICPC

Skin texture symptom/complaint

1.5

47.7

1849

12813

S22

ICPC

Nail symptom/complaint

1.8

47.6

865

4903

C10AA03

ATC

pravastatin; oral

1.8

47.6

882

5034

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

47.6

3697

29023

S20

ICPC

Corn/callosity

2.9

47.6

309

1093

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

47.5

494

2256

S02CA02

ATC

flumetasone and antiinfectives; otic

1.8

47.4

843

4743

C07AB08

ATC

celiprolol; oral

2.7

47.4

347

1319

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

47.2

716

3818

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.5

47.0

382

1543

-45

ICPC

Observ/health educat/advice/diet

2.1

47.0

530

2509

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

46.9

1072

6520

C09DB01

ATC

valsartan and amlodipine; oral

2.2

46.8

479

2170

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.5

46.8

370

1473

ZXA10

NOMESCO Finland

Bilateral

1.4

46.8

2695

20147

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

46.7

2105

15039

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

46.6

764

4186

G04BD07

ATC

tolterodine; oral

2.0

46.5

630

3218

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.0

46.5

618

3133

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.3

46.4

446

1960

C10AB02

ATC

bezafibrate; oral

3.9

46.2

196

504

H36.01

ICD-10 Finland

Diabetic maculopathy

3.5

46.2

228

665

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.0

46.2

597

2994

N85.0

ICD-10 Finland

Endometrial glandular hyperplasia

2.8

46.2

312

1133

K04.00

ICD-10 Finland

Hyperemia of pulp

1.8

46.0

778

4306

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.3

46.0

426

1839

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.5

46.0

365

1456

T29

ICPC

Endocr/metab/nutr sympt/compl other

2.7

46.0

334

1265

SPAT1151

SPAT

Treatment of major wounds

3.5

45.9

219

622

A10BD15

ATC

metformin and dapagliflozin; systemic

4.6

45.9

165

363

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.8

45.9

306

1102

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

45.8

6907

59146

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.4

45.7

399

1674

E87.5

ICD-10 Finland

Hyperkalaemia

3.4

45.7

231

687

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.9

45.7

745

4075

J01DA06

ATC

[U] cefuroxime; systemic

1.4

45.6

2357

17275

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.4

45.6

418

1797

R75

ICPC

Sinusitis acute/chronic

1.8

45.5

798

4473

N05BE01

ATC

buspirone; oral

2.2

45.4

495

2312

E78.11

ICD-10 Finland

Other hypertriglyceridemia

5.7

45.4

134

237

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.7

45.3

327

1234

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.0

45.3

635

3287

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

45.3

1934

13664

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

45.2

738

4036

R03AK11

ATC

formoterol and fluticasone; inhalant

2.3

45.1

424

1845

SPAT1172

SPAT

Guidance concerning hydration

2.9

45.0

286

999

N02AJ13

ATC

tramadol and paracetamol; systemic

2.6

45.0

340

1319

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.5

44.9

370

1504

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.1

44.9

505

2388

SPAT1359

SPAT

Use of symptom diary

2.3

44.9

420

1826

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.2

44.8

475

2186

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.2

44.8

460

2090

SPAT1379

SPAT

Health check-up of pregnant person

1.5

44.7

1967

13977

M01AB55

ATC

diclofenac, combinations; oral

1.7

44.7

921

5432

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.7

44.4

881

5136

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.5

44.4

1740

12073

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

44.3

682

3655

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

44.3

481

2239

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.2

44.3

241

758

RD160

NOMESCO Finland

9.6

44.0

C07AB05

ATC

betaxolol; oral

2.5

43.9

357

1442

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.7

43.8

313

1174

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

43.7

1017

6210

A11CC03

ATC

alfacalcidol; systemic

2.5

43.7

349

1394

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

43.6

626

3269

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.9

43.4

661

3528

XF404

NOMESCO Finland

Ambulatory ECG

1.6

43.2

1275

8294

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

43.2

582

2967

M54.3

ICD-10 Finland

Sciatica

1.7

43.1

885

5211

J96.9

ICD-10 Finland

Respiratory failure, unspecified

6.0

43.1

121

201

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.1

43.1

530

2604

A08AX01

ATC

rimonabant; oral

24.5

43.1

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.0

43.1

543

2694

63703

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia levis

3.0

43.0

258

869

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.8

43.0

288

1041

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.3

42.9

431

1937

SPAT1284

SPAT

Extensive health certificate

2.1

42.9

503

2421

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

3.0

42.9

257

864

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

5.1

42.7

139

276

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.9

42.6

270

941

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

42.6

1065

6637

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

42.6

1058

6582

SPAT1243

SPAT

Psychiatric/psychological examination

2.1

42.6

524

2577

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.8

42.5

828

4798

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.5

42.5

287

5986

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

42.4

1427

9575

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.3

42.3

220

669

N03AE01

ATC

clonazepam; systemic

1.7

42.2

864

5084

SFA00

NOMESCO Finland

Small filling

1.4

42.2

2091

15197

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.2

42.1

444

2042

A05

ICPC

Feeling ill

1.7

42.1

984

6017

C09AA04

ATC

perindopril; oral

1.9

42.0

653

3511

PH2DE

NOMESCO Finland

Ultrasound examination of bloodflow in veins of lower extremity with Doppler method

2.2

42.0

432

1964

S01

ICPC

Pain/tenderness of skin

1.9

41.7

642

3439

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.2

41.6

460

2159

R52.0

ICD-10 Finland

Acute pain

2.0

41.6

528

2628

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.7

41.6

287

1054

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

1.7

41.6

976

5978

D05AX02

ATC

calcipotriol; topical

1.9

41.6

592

3081

Z72.0

ICD-10 Finland

Tobacco use

2.2

41.4

433

1981

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

41.4

1480

10062

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

41.4

492

2382

H60.8

ICD-10 Finland

Other otitis externa

2.2

41.2

455

2137

A29

ICPC

General symptom/complaint other

1.5

41.1

1550

10656

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.0

41.1

542

2740

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.7

41.0

816

4758

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.4

40.9

204

601

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

5.3

40.9

128

243

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.0

40.9

134

268

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

40.9

1000

6193

NHQ40

NOMESCO Finland

Amputation of toe

3.1

40.8

230

742

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

0.5

40.8

411

7593

K29.7

ICD-10 Finland

Gastritis, unspecified

2.1

40.8

504

2483

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.2

40.8

431

1983

L11

ICPC

Wrist symptom/complaint

1.6

40.7

1244

8154

RD250

NOMESCO Finland

+∞

40.6

D09AB01

ATC

zinc bandage without supplements; topical

2.6

40.5

316

1248

O82.0

ICD-10 Finland

Delivery by elective caesarean section

1.8

40.5

771

4437

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.1

40.5

450

2119

K92.1

ICD-10 Finland

Melaena

1.9

40.4

624

3348

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

40.4

883

5298

Z08

ICPC

Social welfare problem

3.0

40.4

237

787

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

3.3

40.3

211

646

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.5

40.2

195

563

JAF11

NOMESCO Finland

Laparoscopic repair of umbilical hernia

4.6

40.2

144

317

B80

ICPC

Iron deficiency anaemia

2.5

40.1

328

1331

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

40.0

646

3519

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.8

39.9

2884

36249

N07BA03

ATC

varenicline; oral

1.7

39.9

842

5000

H3603, E113

ICD-10 Finland

4.0

39.8

163

408

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

39.8

1072

6810

E03

ICD-10 Finland

Other hypothyroidism

1.7

39.8

865

5182

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.3

39.7

368

1592

L84

ICD-10 Finland

Corns and callosities

2.1

39.7

486

2383

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.5

39.6

317

1270

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

39.5

839

4991

ZX120

NOMESCO Finland

Intravenous

1.5

39.4

1362

9186

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.7

39.3

280

1051

R35

ICD-10 Finland

Polyuria

1.7

39.3

816

4820

N05AE04

ATC

ziprasidone; systemic

3.9

39.3

165

422

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.6

39.3

1002

6276

S17

ICPC

Abrasion/scratch/blister

2.4

39.2

349

1479

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

4.9

39.2

131

268

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.9

39.1

595

3176

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

22.0

39.1

M01AB08

ATC

etodolac; oral

1.6

39.0

1117

7208

C03EA02

ATC

trichlormethiazide and potassium-sparing agents; oral

3.0

39.0

227

750

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.7

39.0

913

5588

R03BB01

ATC

ipratropium bromide; inhalant

2.2

38.9

420

1951

Z13.5

ICD-10 Finland

Special screening examination for eye and ear disorders

3.6

38.9

181

506

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

38.7

2143

15867

H70

ICPC

Otitis externa

2.4

38.5

350

1498

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

1.7

38.5

784

4608

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.8

38.5

252

899

Z00.8

ICD-10 Finland

Other general examinations

1.6

38.4

1105

7138

SPAT1238

SPAT

Brief therapy

2.3

38.4

373

1653

F32.8

ICD-10 Finland

Other depressive episodes

2.6

38.2

281

1075

I11

ICD-10 Finland

Hypertensive heart disease

6.1

38.2

106

174

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

2.1

38.2

445

2141

R09

ICPC

Sinus symptom/complaint

1.5

38.1

1308

8810

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.6

38.1

992

6245

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.9

38.1

610

3316

M75

ICD-10 Finland

Shoulder lesions

1.8

38.0

629

3456

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

38.0

1763

12638

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

38.0

1461

10084

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.1

38.0

211

675

R31

ICD-10 Finland

Unspecified haematuria

1.6

37.9

1176

7734

N06AA10

ATC

nortriptyline; systemic

2.3

37.9

366

1615

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.3

37.8

196

596

JAG51

NOMESCO Finland

Laparoscopic repair of internal hernia

195.3

37.8

KMAK

NOMESCO Finland

1.2

37.6

9538

85726

M43.1

ICD-10 Finland

Spondylolisthesis

1.9

37.6

564

2995

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.7

37.5

826

4965

H60.3

ICD-10 Finland

Other infective otitis externa

2.3

37.5

370

1652

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.3

37.5

358

1572

MAC96

NOMESCO Finland

Other induction or advancement of labour

2.1

37.5

442

2136

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.8

37.4

628

3467

M54.1

ICD-10 Finland

Radiculopathy

1.9

37.4

592

3203

H60

ICD-10 Finland

Otitis externa

1.7

37.3

729

4230

N18

ICD-10 Finland

Chronic kidney disease

4.4

37.2

137

310

N02AC04

ATC

dextropropoxyphene; oral

2.1

37.2

440

2128

A77

ICPC

Viral disease other/NOS

1.9

37.2

593

3220

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

2.3

37.1

347

1509

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.4

37.1

336

1439

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.5

37.1

1534

10747

SPAT1167

SPAT

Insertion of urinary catheter

2.3

37.1

363

1613

S09

ICPC

Infected finger/toe

2.1

37.0

455

2239

L40.5

ICD-10 Finland

Arthropathic psoriasis

2.5

36.8

292

1165

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.3

36.8

367

1646

E86

ICD-10 Finland

Volume depletion

2.5

36.8

288

1140

G93.2

ICD-10 Finland

Benign intracranial hypertension

7.7

36.6

112

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.1

36.4

423

2032

C01BD01

ATC

amiodarone; systemic

2.3

36.3

355

1576

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.7

36.3

253

939

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.1

36.2

442

2168

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.8

36.2

237

845

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.0

36.2

462

2307

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

36.1

777

4642

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.7

36.1

252

936

N06AA04

ATC

clomipramine; systemic

2.5

36.1

294

1189

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.8

36.1

241

870

J01

ICD-10 Finland

Acute sinusitis

1.7

36.0

806

4870

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.6

35.9

1009

6477

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.9

35.9

154

402

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

35.9

999

6397

NG1DA

NOMESCO Finland

X-ray of knees

2.5

35.9

281

1115

ECB00

NOMESCO Finland

Suture of gingiva

1.9

35.9

542

2886

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

35.8

879

5449

S06.0

ICD-10 Finland

Concussion

1.5

35.8

1506

10589

WX892

NOMESCO Finland

Monitored bed care

1.6

35.7

1022

6593

CK2S4

SPAT

4.0

35.6

148

376

K03.66

ICD-10 Finland

Tooth plaque

1.6

35.6

947

5995

SPAT1357

SPAT

Monitoring of problem during pregnancy

2.0

35.6

486

2492

R60.1

ICD-10 Finland

Generalized oedema

4.2

35.5

137

325

N07BB01

ATC

disulfiram; oral

1.8

35.5

683

3943

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.1

35.5

436

2142

K08.80

ICD-10 Finland

Toothache NOS

1.5

35.5

1314

8993

WX872

NOMESCO Finland

Intensive care

1.8

35.4

661

3780

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.9

35.4

225

789

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

35.4

935

5909

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.0

35.3

464

2341

Angiography of the heart and coronary arteries

1.8

35.3

623

3500

G03DB01

ATC

dydrogesterone; oral

1.4

35.2

2285

17360

-34

ICPC

Blood test

2.0

35.2

459

2313

A12AA04

ATC

calcium carbonate; oral

2.8

35.2

237

862

N06AX18

ATC

reboxetine; oral

3.0

35.2

213

724

E87.6

ICD-10 Finland

Hypokalaemia

2.1

35.1

422

2055

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.9

35.1

554

2996

S94

ICPC

Ingrowing nail

2.7

35.1

249

934

M77.4

ICD-10 Finland

Metatarsalgia

1.6

35.0

842

5188

R06AX13

ATC

loratadine; oral

1.3

34.9

2574

19944

N48.1

ICD-10 Finland

Balanoposthitis

2.4

34.9

303

1269

D07AB08

ATC

desonide; topical

1.4

34.9

1622

11620

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.3

34.7

325

1413

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

34.6

275

1099

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.9

34.6

528

2823

D01AE15

ATC

terbinafine; topical

1.6

34.5

940

5986

I82.9

ICD-10 Finland

Embolism and thrombosis of unspecified vein

2.6

34.5

263

1027

N17

ICPC

Vertigo/dizziness

1.5

34.4

1470

10364

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

34.4

495

2590

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

4.4

34.3

126

285

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.4

34.3

1627

11707

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

8.1

34.2

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.0

34.2

442

2217

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.8

34.0

578

3207

R10.0

ICD-10 Finland

Acute abdomen

1.9

33.9

485

2531

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

33.8

703

4157

QBJ00

NOMESCO Finland

Liposuction in trunk

4.2

33.8

130

308

E000006

ATC

1.5

33.8

1044

6860

L30.3

ICD-10 Finland

Infective dermatitis

1.9

33.7

502

2660

D01BA02

ATC

terbinafine; oral; topical

1.3

33.7

3656

29865

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.6

33.6

987

6405

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

33.5

745

4490

F41.00

ICD-10 Finland

Moderate panic disorder

2.3

33.5

308

1328

C07AB12

ATC

nebivolol; oral

2.0

33.4

423

2107

K02

ICD-10 Finland

Dental caries

1.5

33.3

1121

7511

40199

ICD-8 Finland

Essential benign hypertension

3.0

33.2

200

677

D73

ICPC

Gastroenteritis presumed infection

1.9

33.2

502

2674

JAF10

NOMESCO Finland

Repair of umbilical hernia

2.2

33.2

362

1690

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.2

33.2

355

1646

C07AA05

ATC

propranolol; systemic

1.3

33.2

3144

25229

M13.9

ICD-10 Finland

Arthritis, unspecified

1.5

33.2

1040

6856

J01EA01

ATC

trimethoprim; systemic

1.3

33.1

3865

31849

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.4

33.1

292

1235

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.3

33.1

312

1364

A10BD05

ATC

metformin and pioglitazone; systemic

5.4

33.0

101

188

P74

ICPC

Anxiety disorder/anxiety state

1.8

32.9

636

3676

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.4

32.9

287

1208

B01AX06

ATC

[U] rivaroxaban; oral

2.3

32.8

307

1337

R51

ICD-10 Finland

Headache

1.6

32.7

823

5136

J35.1

ICD-10 Finland

Hypertrophy of tonsils

2.3

32.6

319

1419

R06AX22

ATC

ebastine; oral

1.3

32.6

2818

22333

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

32.6

2556

19978

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.6

32.5

857

5413

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

32.5

1169

7947

LCA10

NOMESCO Finland

Curettage of body of uterus

2.0

32.4

418

2098

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.7

32.4

232

875

H02BX01

ATC

methylprednisolone, combinations; systemic

1.7

32.4

640

3729

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.0

32.3

426

2158

N17.8

ICD-10 Finland

Other acute renal failure

3.3

32.3

164

493

N05AF01

ATC

flupentixol; systemic

2.5

32.2

254

1013

-31

ICPC

Medical examin/health eval partial

1.5

32.2

998

6559

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.0

32.2

418

2104

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.1

32.2

374

1797

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

32.1

822

5153

D01

ICPC

Abdominal pain/cramps general

1.4

32.0

1682

12320

R55

ICD-10 Finland

Syncope and collapse

1.5

32.0

1326

9286

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

1.3

31.9

2443

19015

R28

ICPC

Limited function/disability (R)

3.0

31.9

190

638

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.0

31.9

437

2246

XA421

NOMESCO Finland

Nocturnal polygraphy

5.3

31.8

188

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

3.4

31.8

156

456

J03.0

ICD-10 Finland

Streptococcal tonsillitis

1.9

31.8

508

2762

G63.2

ICD-10 Finland

Diabetic polyneuropathy

5.1

31.8

102

201

R07

ICPC

Sneezing/nasal congestion

1.5

31.7

1062

7105

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.7

31.7

639

3741

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.6

31.7

798

4982

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.8

31.7

208

746

SPAT1146

SPAT

Puncture of abscess or incision of skin

2.3

31.6

290

1251

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

31.6

1285

8969

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

31.5

1132

7693

F31

ICD-10 Finland

Bipolar affective disorder

2.6

31.5

232

891

B01AE07

ATC

dabigatran etexilate; oral

1.9

31.5

459

2414

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

31.4

545

3043

UJF92

NOMESCO Finland

Capsular endoscopy

2.2

31.4

339

1578

J01DC02

ATC

cefuroxime; systemic

1.6

31.4

909

5881

M54.8

ICD-10 Finland

Other dorsalgia

1.7

31.3

607

3516

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.1

31.3

348

1641

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.7

31.2

659

3917

C08DA01

ATC

verapamil; systemic

1.8

31.1

512

2809

K28

ICPC

Limited function/disability (K)

2.5

31.0

249

1004

L03.3

ICD-10 Finland

Cellulitis of trunk

3.7

31.0

140

384

C02LM02

ATC

3.4

30.9

155

462

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.8

30.9

135

360

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

1.8

30.9

516

2849

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.5

30.9

1065

7175

N06AB08

ATC

fluvoxamine; oral

2.0

30.8

424

2183

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.0

30.7

124

308

SPAT1053

SPAT

Memory test

1.4

30.7

1431

10251

F60.8

ICD-10 Finland

Other specific personality disorders

3.5

30.7

149

433

J01CA08

ATC

pivmecillinam; oral

1.2

30.6

6698

58936

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.0

30.5

418

2146

W19

ICD-10 Finland

Unspecified fall

1.5

30.5

1252

8749

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.4

30.5

1626

11940

R04.2

ICD-10 Finland

Haemoptysis

2.0

30.5

401

2030

WX111

NOMESCO Finland

Local infiltration anesthesia

2.0

30.5

400

2020

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.5

30.5

252

1031

E65

ICD-10 Finland

Localized adiposity

8.5

30.5

B35.3

ICD-10 Finland

Tinea pedis

1.8

30.5

550

3115

N39.3

ICD-10 Finland

Stress incontinence

1.5

30.4

1005

6705

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

3.8

30.3

130

341

R06AX27

ATC

desloratadine; oral

1.2

30.3

4667

39630

Z25.1

ICD-10 Finland

Need for immunization against influenza

1.6

30.3

782

4913

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.1

30.3

337

1592

XKD00

NOMESCO Finland

Uroflowmetry

1.4

30.3

1776

13253

K81.9

ICD-10 Finland

Cholecystitis, unspecified

3.2

30.2

166

529

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

30.2

318

1463

N18.0

ICD-10 Finland

End-stage renal disease

3.1

30.1

173

568

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.6

29.9

792

5006

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

29.9

838

5373

N05AH02

ATC

clozapine; systemic

2.2

29.8

313

1442

QBA10

NOMESCO Finland

Incision of skin of trunk

2.9

29.7

184

635

NK4EA

NOMESCO Finland

Joint X-ray examintion with load or wrench not elsewhere classified

3.5

29.7

141

403

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

29.6

400

2044

N06AX22

ATC

agomelatine; oral

2.0

29.5

362

1782

P25

ICPC

Phase of life problem adult

1.7

29.5

676

4114

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

29.4

230

915

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.9

29.3

471

2563

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

29.3

647

3893

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.8

29.3

479

2627

A07AA02

ATC

nystatin; oral

1.6

29.2

794

5056

D02

ICPC

Abdominal pain epigastric

1.6

29.2

838

5408

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

2.1

29.1

336

1613

T78.4

ICD-10 Finland

Allergy, unspecified

1.6

29.1

737

4606

SPAT1081

SPAT

Cardiorespiratory global assessment

1.7

29.1

684

4187

K02.2

ICD-10 Finland

Caries of cementum

1.7

29.1

568

3296

CL2S4

SPAT

4.0

29.1

119

300

RD130

NOMESCO Finland

20.5

29.0

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.2

28.9

3878

32402

J04AB02

ATC

rifampicin; systemic

2.8

28.9

187

665

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.5

28.9

230

923

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

28.9

1002

6754

N06AX17

ATC

milnacipran; oral

2.7

28.9

208

789

-56

ICPC

Dressing/pressure/compress/tamponade

2.4

28.9

254

1072

M01AB51

ATC

indometacin, combinations; oral, rectal

2.1

28.9

331

1584

D91

ICPC

Abdominal hernia other

2.8

28.8

186

661

R4180

NOMESCO Finland

Podiatric therapy

3.0

28.8

174

592

SPAT1057

SPAT

Peak expiratory flow measurement

2.1

28.8

333

1600

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

28.8

746

4692

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

2.4

28.7

248

1040

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.3

28.7

265

1148

M01AH03

ATC

valdecoxib; oral

1.5

28.7

888

5832

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.2

28.7

155

489

L05.9

ICD-10 Finland

Pilonidal cyst without abscess

2.6

28.7

216

839

C09BA04

ATC

perindopril and diuretics; systemic

2.5

28.6

237

971

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.1

28.6

327

1563

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.0

28.6

364

1821

ZZA00

NOMESCO Finland

Split skin graft

2.0

28.5

363

1813

R03

ICPC

Wheezing

2.9

28.5

176

606

Z01.7

ICD-10 Finland

Laboratory examination

1.4

28.5

1584

11713

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.0

28.5

167

558

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

28.4

464

2541

D09

ICPC

Nausea

1.7

28.3

656

4000

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.0

28.3

348

1714

N85.1

ICD-10 Finland

Endometrial adenomatous hyperplasia

3.0

28.3

166

555

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.8

28.3

468

2575

D06

ICPC

Abdominal pain localized other

1.4

28.2

1213

8554

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

3.0

28.2

165

550

C10AC01

ATC

colestyramine; oral

2.0

28.2

378

1926

JKA20

NOMESCO Finland

Cholecystectomy

2.1

28.2

324

1553

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.5

28.0

994

6735

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

2.8

28.0

188

683

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

28.0

1281

9144

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

2.5

27.9

219

871

G04BD09

ATC

trospium; oral

2.1

27.9

312

1476

S83.4

ICD-10 Finland

Sprain and strain involving (fibular)(tibial) collateral ligament of knee

1.8

27.9

478

2660

EMB10

NOMESCO Finland

Tonsillectomy

1.5

27.9

998

6779

R5110

SPAT

2.1

27.9

331

1609

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3496

17908

2.12

323.31

8.6

7.4

5.3

5.0

kpa

36.22

3359

17138

(3003396) Base excess in Arterial blood by calculation

3495

17904

2.12

323.31

8.6

7.3

1.4

0.9

mmol/l

8.21

2833

13981

(3019198) Lymphocytes [#/volume] in Blood

12930

98807

1.70

322.53

6.5

5.9

2.0

1.9

e9/l

6.16

11581

87867

(3013707) Erythrocyte sedimentation rate by Westergren method

17168

141916

1.80

321.67

4.9

3.9

16.0

10.6

mm/h

307.65

15945

132398

(3019069) Monocytes/100 leukocytes in Blood

12015

90170

1.69

319.73

6.9

6.3

8.1

8.4

37.79

11308

84854

(3006504) Eosinophils/100 leukocytes in Blood

11950

89672

1.68

317.10

6.6

6.0

2.8

2.9

2.52

11180

83889

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1218

3763

3.36

316.26

3.6

2.9

25.0

24.5

mmol/l

2.90

1085

3301

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

6902

44831

1.77

309.43

2.5

2.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4579

26212

1.93

308.83

2.0

1.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

3976

19969

2.20

307.65

7.8

7.2

104.3

104.6

mmol/l

3.88

3866

19558

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8278

43243

2.42

307.65

2.7

2.2

3.2

2.8

mg/l

48.30

7370

37047

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

21050

179954

2.80

307.65

6.3

4.6

2.0

2.1

mu/l

0.15

19727

167195

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

9249

57190

2.03

307.65

2.9

2.5

50.1

58.6

u/l

12.96

8564

52894

(3022948) Iron [Moles/volume] in Serum or Plasma

5393

26933

2.31

307.65

3.1

2.4

12.4

13.9

umol/l

38.84

4998

25089

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10195

62546

2.12

307.65

3.4

3.2

33.0

32.8

u/l

0.10

9655

59521

(3022313) Gas panel - Capillary blood

2473

6636

4.05

307.65

3.7

3.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5065

24646

2.35

307.65

3.1

2.4

2.5

2.4

g/l

30.88

4671

22920

(3013115) Eosinophils [#/volume] in Blood

13102

99180

1.74

307.65

6.7

6.1

0.2

e9/l

28.29

11709

87911

(3013826) Glucose [Moles/volume] in Serum or Plasma

16116

105602

2.72

307.65

6.3

4.4

7.2

6.5

mmol/l

204.50

15113

97445

(3002032) Base excess in Venous blood by calculation

3071

14423

2.30

307.65

5.0

4.1

2.0

1.8

mmol/l

1.49

2556

11755

(3020779) Urea [Moles/volume] in Serum or Plasma

3000

14083

2.30

307.65

10.1

7.7

11.3

8.8

mmol/l

53.93

2860

13496

(3044640) Blood type and Crossmatch panel - Blood

9186

59217

1.91

307.65

2.5

2.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

11870

77254

2.10

307.65

7.7

5.7

1.2

mmol/l

13.07

10854

70288

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

12839

91123

1.91

307.65

4.6

3.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

18935

152556

2.30

307.65

5.1

4.0

14.6

pmol/l

1.91

17536

140534

(3013512) EKG study

8143

48089

2.07

307.65

4.8

3.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

988

919

11.18

307.65

4.0

2.6

44.3

16.6

mu/l

44.31

947

854

(3001604) Monocytes [#/volume] in Blood

12638

95529

1.71

307.65

6.4

5.9

0.6

e9/l

63.40

11130

83444

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

13214

85455

2.27

307.65

8.5

6.4

1.2

mmol/l

12.82

11236

72335

(3009508) Creatinine [Moles/volume] in Urine

11084

52146

3.15

307.65

3.8

3.2

7.9

7.7

mmol/l

4.59

9288

44391

(3006315) Basophils [#/volume] in Blood

12716

95914

1.72

307.65

6.4

5.9

0.0

e9/l

6.98

11169

83725

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1212

3223

3.91

307.65

1.8

2.3

1.1

0.8

nmol/l

19.89

963

2756

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

21198

184343

2.70

307.65

6.4

4.0

6.5

5.8

mmol/l

307.65

19761

170524

(3012095) Magnesium [Moles/volume] in Serum or Plasma

6171

26847

2.77

307.65

3.2

3.6

0.8

mmol/l

1.46

5836

25115

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1087

3070

3.67

307.65

3.7

3.0

—

(3037467) Urinalysis macro (dipstick) panel - Urine

16648

132387

1.91

307.65

5.2

4.0

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6935

41713

1.94

307.65

2.0

1.8

1.1

mg/l

0.63

5397

31416

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

16534

134126

1.81

307.65

4.2

2.9

58.3

43.2

u/l

62.74

15533

126579

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

18683

142698

2.58

307.65

8.5

7.3

81.5

76.0

u/l

50.30

17857

134581

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

10019

63630

2.01

307.65

4.5

3.1

48.9

63.7

ng/l

0.58

6791

38115

(3027801) Oxygen [Partial pressure] in Arterial blood

3495

17897

2.12

307.65

8.6

7.4

11.0

13.0

kpa

127.82

3350

17125

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3446

15735

2.40

307.65

2.3

0.2

g/l

0.59

3206

14723

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

11827

68866

2.46

307.65

2.5

1.8

95.4

97.5

pmol/l

5.14

7253

35893

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1214

3638

3.47

307.65

2.5

141.9

102.3

ug/min

1.86

755

2228

(3007853) Bacteria identified in Skin by Aerobe culture

4221

21192

2.21

307.65

2.1

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2108

5915

3.82

307.65

3.8

3.7

24.8

mmol/l

0.51

1982

5510

(3026493) Urate [Moles/volume] in Serum or Plasma

9068

46166

2.58

307.65

3.0

2.4

3668.2

3691.0

umol/l

0.02

7919

40538

(3001122) Ferritin [Mass/volume] in Serum or Plasma

12775

88842

1.97

307.65

3.9

2.8

111.0

109.7

ug/l

0.26

11994

83410

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3964

21162

2.05

307.65

5.3

4.1

29.5

32.5

61.06

3140

14771

(3012516) Albumin [Mass/volume] in Urine

10534

46389

3.32

307.65

3.8

3.2

232.3

448.3

mg/l

7.82

7280

28849

(3031040) Bacteria [#/volume] in Urine by Automated count

15728

125940

1.77

307.65

5.4

4.0

1492.0

1415.0

e6/l

0.07

301

1544

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3248

9442

3.84

307.65

3.7

3.4

5.3

5.1

kpa

21.33

3043

8767

(3023368) Bacteria identified in Blood by Culture

7734

43628

2.16

307.65

4.9

4.1

—

(3026008) Bacteria identified in Urine by Culture

8178

52080

1.88

307.65

3.4

2.7

—

(3042936) Bacteria identified in Isolate by Culture

4614

24596

2.09

307.65

2.4

2.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

20788

182903

2.29

307.65

5.1

3.6

1.6

1.3

mmol/l

307.65

19351

170332

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3934

16850

2.61

307.65

2.0

2.2

337.3

378.8

nmol/l

33.99

3598

15625

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

13896

93468

2.21

307.65

5.9

6.1

10.6

11.0

umol/l

2.81

13176

88475

(3020682) Albumin/Creatinine [Ratio] in Urine

11109

48599

3.46

307.65

4.9

3.9

12.6

8.9

mg/mmol

8.81

7680

30411

(3021960) Folate [Moles/volume] in Serum or Plasma

7279

37363

2.38

307.65

1.8

1.5

20.5

20.4

nmol/l

0.20

6432

32256

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3128

9000

3.86

307.65

3.6

3.4

1.7

1.6

mmol/l

0.96

2350

6566

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6952

35510

2.37

307.65

2.1

1.6

34656356.4

39545417.8

pmol/l

0.26

5973

29933

(3019309) Folate [Moles/volume] in Red Blood Cells

6292

27920

2.72

307.65

2.1

1.7

1229.8

1158.4

nmol/l

7.50

5139

21270

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3093

14451

2.32

307.65

5.0

4.1

5.9

5.8

kpa

9.69

3017

14041

(3019550) Sodium [Moles/volume] in Serum or Plasma

21967

195771

3.23

307.65

23.9

13.3

139.7

139.6

mmol/l

4.53

21645

190755

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

8607

41373

2.72

307.65

3.6

2.8

1234.3

1115.7

ng/l

1.67

7078

35085

(3009343) pH of Capillary blood

3225

9319

3.86

307.65

3.7

3.4

7.4

5.24

351

1256

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5627

20637

3.28

307.65

6.4

6.1

1.1

1.0

mmol/l

30.40

5353

19331

(3023103) Potassium [Moles/volume] in Serum or Plasma

21983

196348

3.21

307.65

24.1

13.4

4.0

3.9

mmol/l

43.18

21623

190925

(3032080) INR in Blood by Coagulation assay

11068

67128

2.24

307.65

10.2

7.6

1.2

inr

2.91

3254

20138

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

21235

171010

3.80

307.65

9.6

4.9

43.3

38.6

mmol/mol

307.65

20179

159691

(3015377) Calcium [Moles/volume] in Serum or Plasma

8836

58863

1.81

307.65

3.1

3.4

2.3

2.4

mmol/l

13.62

7726

51998

(3012544) pH of Venous blood

3184

14973

2.31

307.65

5.0

4.1

7.4

0.18

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4733

22670

2.37

307.65

3.2

2.5

20.6

23.7

48.14

4114

19465

(3024561) Albumin [Mass/volume] in Serum or Plasma

13081

74155

2.75

307.65

5.6

4.8

35.4

36.0

g/l

33.27

12383

68932

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

12437

76250

2.36

307.65

3.1

2.2

70.6

1253.2

nmol/l

0.50

11508

69695

(42870588) Differential panel, method unspecified - Blood

9067

63666

1.70

305.82

6.1

6.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4301

24187

1.95

305.43

1.9

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

21534

193577

2.53

302.95

6.2

4.4

2.6

2.8

mmol/l

227.76

20216

180606

(3024354) Oxygen [Partial pressure] in Venous blood

2539

11727

2.31

302.37

4.3

3.4

4.8

4.6

kpa

1.97

2467

11354

(3002030) Lymphocytes/100 leukocytes in Blood

12246

93227

1.66

301.05

6.7

6.0

27.1

28.9

70.87

11452

87311

(3016502) Oxygen saturation in Arterial blood

3159

15977

2.13

300.45

8.9

7.8

94.8

96.0

25.54

3062

15363

(3022096) Basophils/100 leukocytes in Blood

11572

86855

1.66

300.44

6.6

6.1

0.6

0.7

27.37

10822

81274

(4146454)

679

1451

4.79

294.10

2.7

2.8

—

(3018010) Neutrophils/100 leukocytes in Blood

12074

91915

1.65

294.01

6.5

5.8

58.8

56.6

90.64

11320

86408

(3013650) Neutrophils [#/volume] in Blood by Automated count

13966

110401

1.66

292.61

9.1

9.0

4.6

4.0

e9/l

186.91

12385

96848

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

21191

189671

2.33

292.17

5.7

4.0

1.3

1.5

mmol/l

307.65

19863

177411

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

21279

190972

2.35

288.33

5.7

4.0

4.4

4.7

mmol/l

307.65

20047

179278

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

769

1849

4.27

287.03

1.2

1.3

21.4

31.2

nmol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

21670

196132

2.55

286.32

20.7

12.2

21.1

22.2

mg/l

6.01

19796

151230

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

8953

63776

1.66

278.30

3.9

3.1

—

0.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

3624

19811

1.98

276.80

25.3

20.2

1.3

inr

0.46

503

3065

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2513

11981

2.23

276.02

4.7

3.9

105.2

86.0

ng/l

13.56

2173

10508

(3026782) Osmolality of Urine

5447

33946

1.79

276.00

3.3

2.6

565.6

543.1

mosm/kgh2o

8.75

4726

28885

(3019225) pH of Specimen

3140

16355

2.06

274.39

4.6

4.1

—

(3019060) Gas panel - Arterial blood

2198

10005

2.32

269.36

5.4

4.9

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1735

7112

2.56

267.85

4.4

3.4

25.4

25.2

mmol/l

1.17

1697

6894

(3018418) pH of Serum or Plasma

7385

50708

1.67

260.56

5.0

4.0

7.4

0.93

1590

9632

(40768797) Stomach Pathology biopsy report

4247

24975

1.86

258.27

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1602

6524

2.56

250.22

5.4

3.7

49.6

48.9

0.47

1588

6452

(3021901) Oxygen saturation in Capillary blood

904

2687

3.46

248.73

3.1

2.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7464

51979

1.64

245.93

2.4

2.1

186.2

198.8

u/l

0.65

7030

48935

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

20321

181380

1.96

244.58

18.2

11.1

85.2

85.7

ml/min/173m2

2.25

17488

148801

(3004119) Hemoglobin [Mass/volume] in Venous blood

2020

9255

2.30

242.73

4.3

3.4

129.7

129.8

g/l

0.04

1974

9041

(3028626) Oxygen [Partial pressure] in Capillary blood

1061

3600

3.04

234.43

3.3

3.2

8.3

8.6

kpa

4.83

997

3353

(3035350) Ketones [Presence] in Urine by Test strip

12005

94557

1.56

228.59

4.3

3.3

0.0

estimate

1.91

2658

17705

(3009261) Glucose [Presence] in Urine by Test strip

12099

95799

1.55

222.47

4.4

3.3

0.0

estimate

0.93

2541

17810

(3002582) Erythrocytes [#/volume] in Urine

7550

53905

1.59

218.41

3.8

3.0

79.3

82.0

e6/l

0.06

6005

40746

(3021601) Nitrite [Presence] in Urine by Test strip

11959

94911

1.54

214.14

5.9

4.5

0.0

estimate

0.05

2747

18195

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

883

2850

3.18

212.30

1.1

40.2

4149.2

iu/ml

0.67

191

673

(3000991) Gas panel - Venous blood

2564

13625

1.99

208.12

10.3

8.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2753

14998

1.95

207.86

9.8

8.1

124.3

121.6

g/l

8.90

2679

14429

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

564

1388

4.14

203.73

1.5

1.3

1.8

1.4

nmol/l

9.99

518

1235

(3018095) Leukocytes [#/volume] in Urine

8681

64834

1.54

201.71

4.3

3.5

85.7

85.1

e6/l

0.02

6433

44365

(3015736) pH of Urine

9567

73047

1.53

200.23

4.0

3.1

5.9

5.8

—

(3027945) Reticulocytes/100 erythrocytes in Blood

3071

17602

1.86

197.77

2.6

2.0

1.7

28.72

2716

15775

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

22240

208075

2.60

196.57

13.7

9.5

30.7

26.0

u/l

141.80

21710

201548

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1367

5802

2.44

194.22

2.3

2.0

1.9

2.1

ug/l

0.37

1214

5169

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

206

189

10.99

193.18

1.0

1.1

73.3

87.2

ug/l

3.42

186

147

(3000850) Epithelial cells [#/volume] in Urine

5477

37117

1.62

192.08

3.1

2.5

7.6

5.9

e6/l

12.73

4819

32341

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6742

48098

1.57

189.66

1.8

1.6

1.7

1.3

mmol/l

101.61

5526

40983

(3021589) Normoblasts [#/volume] in Blood

10785

85252

1.49

186.41

12.0

8.9

0.0

e9/l

2.17

9035

70048

(3027923) C peptide [Moles/volume] in Serum or Plasma

408

835

4.96

185.79

2.1

1.5

1.6

1.1

nmol/l

10.45

316

661

(1616796) Gas panel - Central venous blood

975

3587

2.79

185.31

4.8

3.3

—

(3030467) Casts [#/volume] in Urine by Automated count

6852

49377

1.55

182.87

3.6

3.0

0.5

0.4

e6/l

4.25

5333

36538

(3014111) Lactate [Moles/volume] in Serum or Plasma

2541

14129

1.90

178.72

8.9

7.1

1.5

1.3

mmol/l

6.92

2437

13682

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1540

7148

2.24

177.50

3.8

3.0

1.4

1.3

3.88

1535

7109

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2465

13698

1.89

173.40

5.1

3.6

1.2

mmol/l

14.33

2186

11992

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1504

6981

2.23

173.23

3.8

3.0

0.7

1.33

1455

6689

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

9442

73643

1.48

168.59

4.7

3.4

—

(3037522) Nuclear Ab [Titer] in Serum

4236

27714

1.65

168.02

1.4

461.9

544.1

titre

2.31

805

5647

(3008037) Lactate [Moles/volume] in Venous blood

847

3047

2.85

167.74

4.0

2.8

1.6

1.5

mmol/l

2.44

833

2972

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2260

12368

1.92

166.21

3.1

2.7

168.8

170.9

ng/l

0.09

2005

11229

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1672

8231

2.11

165.71

10.6

9.6

24.6

24.2

mmol/l

4.66

1538

7759

(3033658) Prothrombin time (PT) actual/Normal

6405

46451

1.52

161.84

4.6

3.8

92.2

92.7

0.81

6207

45242

(3038515) Glucose [Moles/volume] in Venous blood

803

2864

2.87

161.53

4.1

2.9

7.9

7.5

mmol/l

3.50

790

2804

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1886

9814

2.00

160.49

8.6

7.1

25.0

24.5

mmol/l

6.49

1780

9108

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2202

12083

1.91

160.34

1.7

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3899

25530

1.63

152.47

2.0

1.7

1.5

1.4

3.96

3393

22672

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2911

17660

1.74

151.88

1.9

1.7

—

(3010421) pH of Blood

1025

4294

2.45

149.14

5.5

3.5

7.4

7.26

899

3630

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1123

4926

2.34

147.37

3.5

3.3

0.3

u/ml

0.03

666

2791

(40761511) CBC panel - Blood by Automated count

21904

206244

2.08

146.20

20.2

11.3

—

(3023520) Reticulocytes [#/volume] in Blood

2272

12951

1.84

146.10

2.6

80.7

69.5

e9/l

30.40

1750

9705

(3027315) Oxygen [Partial pressure] in Blood

924

3725

2.54

145.92

5.5

3.5

8.6

8.8

kpa

4.93

903

3651

(3013290) Carbon dioxide [Partial pressure] in Blood

920

3702

2.55

145.85

5.5

3.5

5.2

5.0

kpa

10.15

899

3629

(3012501) Base excess in Blood by calculation

919

3701

2.54

145.44

5.5

3.5

2.7

2.3

mmol/l

3.24

643

2438

(3029937) Albumin [Presence] in Urine by Test strip

6772

50547

1.48

145.43

4.8

3.7

0.0

estimate

0.75

2582

17671

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1905

10294

1.93

144.64

8.2

7.1

24.9

24.7

mmol/l

1.36

1885

10218

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2822

17190

1.73

144.59

4.2

3.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3297

20943

1.67

144.53

2.7

7.9

8.1

umol/l

0.23

2768

18061

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2898

17798

1.72

144.11

1.9

1.7

—

(36304419) Bacteria [Presence] in Urine

6545

48684

1.48

142.39

3.6

2.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2232

12750

1.83

142.35

2.1

2.6

66.8

66.7

g/l

0.26

2031

11725

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3015

18815

1.69

141.10

3.4

4.4

235.3

239.9

u/l

1.01

2847

17872

(3041096) Erythrocytes [Presence] in Urine by Automated

6999

52864

1.46

140.33

4.1

2.9

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1983

10965

1.88

140.16

1.6

1.9

1.1

1.3

g/l

8.10

1808

10081

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1329

6386

2.15

139.61

6.0

5.0

1.8

1.7

2.14

1275

5944

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1845

10000

1.92

138.58

10.9

9.3

0.6

0.7

3.95

1831

9945

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1848

10022

1.92

138.56

10.8

9.2

1.4

1.96

1830

9960

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1420

7037

2.08

137.54

2.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1812

9788

1.92

137.45

1.7

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

912

3761

2.48

137.15

4.5

3.7

—

(3034770) Mitochondria Ab [Titer] in Serum

1135

5187

2.25

135.02

1.2

1.3

744.6

932.2

titre

0.57

160

(3017181) Myelocytes/100 leukocytes in Blood

2548

15381

1.74

134.19

4.2

4.1

0.8

0.9

1.51

754

4058

(3014007) Fractional oxyhemoglobin in Arterial blood

1838

10056

1.90

133.99

11.0

9.3

93.2

94.1

10.44

1830

10026

(3021440) Promyelocytes/100 leukocytes in Blood

2449

14653

1.75

133.02

4.2

0.1

0.13

718

3744

(1002224) Polysomnography panel

1576

8226

1.98

132.06

1.1

—

(3044889) 12 lead EKG panel

14822

128807

1.42

131.44

4.4

3.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

1137

5274

2.22

130.36

1.2

1.3

121.4

123.5

titre

0.03

108

504

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1684

9033

1.93

130.20

1.8

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

2393

14315

1.75

129.89

2.3

2.7

10.6

10.5

g/l

0.77

2177

13145

(3007930) Methemoglobin/Hemoglobin.total in Blood

1289

6291

2.11

129.83

6.1

5.1

0.8

0.9

7.66

1238

5861

(40767503) Oxygen content in Capillary blood by calculation

834

3396

2.51

128.79

3.1

2.4

16.6

0.01

499

1693

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1506

7826

1.99

127.67

5.4

4.6

24.1

mmol/l

0.16

1317

7083

(3006184) Hemoglobin [Mass/volume] in Capillary blood

874

3666

2.44

126.57

2.5

2.1

131.6

130.9

g/l

0.39

677

2670

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1394

7092

2.03

125.40

1.8

1.7

1.5

g/l

11.26

1203

6131

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1290

6393

2.08

124.64

1.9

1.8

—

(3007164) IgA [Mass/volume] in Serum or Plasma

5442

39995

1.47

122.32

1.5

1.4

2.6

2.3

g/l

26.79

3409

24936

(3018405) Lactate [Moles/volume] in Arterial blood

1136

5415

2.15

121.48

4.5

4.2

1.4

mmol/l

1.15

1112

5322

(3002179) Metamyelocytes/100 leukocytes in Blood

2322

14047

1.73

120.58

3.8

3.9

0.6

0.7

0.63

546

2963

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1501

7943

1.95

120.52

2.1

1.6

5.1

3.2

mg/l

6.42

1377

5262

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4643

33185

1.50

119.56

1.3

9.1

11.4

u/ml

1.62

1795

13407

(3000494) Fungus identified in Specimen by Culture

3285

21815

1.59

118.16

1.5

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

496

1619

3.11

116.64

2.9

2.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1815

10324

1.82

116.32

1.8

2.4

—

(3020891) Body temperature

1237

6200

2.05

115.74

5.9

4.9

—

(3037121) Protein [Mass/volume] in Urine

1179

5809

2.08

115.53

3.1

3.3

0.4

0.3

g/l

3.02

525

2575

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

6123

46444

1.43

115.06

1.3

1.5

1.7

u/ml

0.41

1695

12961

(4010399)

2158

12975

1.73

114.25

1.4

—

(3025159) Blasts/100 leukocytes in Blood

2280

13949

1.70

113.24

4.3

4.2

0.0

0.2

2.69

612

3189

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4831

35143

1.47

112.99

1.4

1.3

34.0

34.2

iu/ml

0.01

1352

11065

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2158

13030

1.72

112.43

3.1

3.4

4.5

pmol/l

2.31

1892

11731

(3009214) Lutropin [Units/volume] in Serum or Plasma

1274

6557

2.00

110.61

1.4

1.3

8.7

10.4

u/l

5.51

1047

5392

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

776

3277

2.42

110.59

1.3

1.2

70.0

160.9

titre

1.16

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

940

4315

2.23

110.30

1.3

—

(3004775) Volume in Urine collected for unspecified duration

401

1198

3.39

109.08

2.3

750.6

663.1

2.60

277

858

(3013139) Helicobacter pylori Ag [Presence] in Stool

2127

12913

1.71

108.44

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

575

2134

2.74

107.05

3.2

3.0

0.8

nmol/l

0.11

449

1587

(44816559) Phosphatidylethanol [Mass/volume] in Blood

837

3715

2.30

106.44

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1397

7578

1.90

103.71

1.4

1.6

11.8

13.9

u/ml

0.30

216

(3017143) Hepatitis C virus Ab [Presence] in Serum

3674

25709

1.51

102.94

1.7

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5106

38196

1.43

101.25

1.8

1.7

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

310

825

3.79

100.41

1.6

2.6

12.8

nmol/l

0.84

250

691

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3743

26415

1.50

100.37

2.3

2.2

30.2

29.6

6.63

3624

25636

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4434

32405

1.46

99.43

4.3

3.4

351.8

513.5

ng/l

1.47

3174

22751

(3023183) Ammonium ion [Moles/volume] in Plasma

779

3452

2.30

99.38

3.4

2.8

36.8

33.8

umol/l

2.26

676

2954

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

679

2840

2.43

98.78

1.7

1.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

495

1790

2.80

96.84

9.5

8.8

8.4

7.1

mmol/l

2.40

407

1479

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4178

30375

1.46

95.85

2.7

3.0

2.5

2.4

mmol/l

6.99

3563

26654

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1550

8973

1.78

92.94

3.1

2.6

0.4

0.2

e6/l

2.10

1526

8695

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1143

6012

1.95

92.88

1.6

109.2

317.5

titre

5.64

235

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

810

3761

2.20

92.25

1.4

1.3

17.7

27.1

u/l

19.53

649

3091

(3000330) Specific gravity of Urine by Test strip

1449

8275

1.80

90.91

4.1

3.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

395

1306

3.06

90.87

2.0

1.4

1.3

g/24h

0.08

(3011985) Renin [Units/volume] in Plasma

592

2435

2.47

89.29

1.5

1.6

79.2

59.9

mu/l

1.45

511

2192

(40760892) CBC W Ordered Manual Differential panel - Blood

5777

45028

1.38

87.93

5.0

4.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

893

4407

2.07

86.78

2.3

3.5

2.6

2.7

ratio

0.02

345

(3028717) Thiamine [Mass/volume] in Blood

117

147

7.99

86.64

1.4

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

938

4718

2.03

86.53

5.0

4.4

3.9

mmol/l

2.27

855

4454

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

912

4541

2.05

86.51

2.3

3.5

39.5

41.8

mg/l

0.25

686

3702

(3034860) Kappa light chains.free [Mass/volume] in Serum

912

4543

2.05

86.40

2.3

3.5

55.1

62.9

mg/l

0.26

692

3695

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3839

28095

1.44

83.66

3.2

2.8

5.2

2.9

e6/l

5.41

2182

14870

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1308

7451

1.80

82.57

1.5

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1492

8848

1.73

81.93

12.4

9.5

—

(3016750) Collection duration of Urine

298

891

3.38

81.03

2.1

2.2

498.3

499.1

min

0.04

217

696

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4055

30157

1.42

80.45

3.0

2.6

1.4

1.2

e6/l

1.34

2384

16833

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

952

4956

1.96

79.56

2.0

1.7

—

(3019150) Specific gravity of Urine by Refractometry

5241

40817

1.37

78.59

4.7

3.6

1.0

kg/l

3.05

892

6050

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2026

13141

1.59

78.39

2.4

2.2

5.8

7.7

ug/l

5.35

1706

11636

(3028271) Lactate [Moles/volume] in Capillary blood

589

2591

2.31

76.37

2.3

1.8

1.7

mmol/l

0.59

579

2533

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

358

1237

2.92

76.22

1.3

5.5

5.2

umol/l

0.61

327

1139

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

532

2251

2.40

75.40

1.3

1.4

300.8

324.6

pmol/l

0.58

429

1729

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1024

5587

1.87

74.19

2.3

639.5

527.7

ug/l

0.18

954

5177

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

920

4862

1.93

73.49

3.6

3.9

1.9

1.4

mg/l

35.56

831

4520

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

545

2397

2.30

70.70

1.2

1.3

38.4

31.9

u/l

0.34

465

2090

(3003694) ABO and Rh group [Type] in Blood

7232

59764

1.30

70.53

1.6

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1338

8032

1.71

70.01

2.1

2.0

38.6

39.4

u/l

0.81

1189

7234

(40760888) Immunoglobulin light chains.free panel - Serum

705

3455

2.07

69.72

2.3

3.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

900

4829

1.90

68.62

1.5

1.4

14.9

15.4

iu/ml

0.03

105

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

491

2092

2.38

68.52

7.4

6.4

11.3

11.4

mg/l

0.24

450

1931

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

775

3969

1.99

67.82

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

1998

13338

1.54

67.68

1.3

277.7

227.5

u/ml

0.73

1873

12330

(3021387) Prolactin [Units/volume] in Serum or Plasma

1455

9011

1.66

67.58

1.6

300.1

312.0

mu/l

0.64

1312

8108

(3025941) Bacteria identified in Stool by Culture

1779

11594

1.58

67.00

1.3

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

832

4390

1.93

66.72

1.5

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

453

1890

2.42

66.26

1.1

1.0

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

941

5203

1.84

65.26

2.0

1.7

32.0

44.0

nmol/l

34.92

901

5070

(40758558) Short blood count panel - Blood

5891

47750

1.31

65.08

6.5

6.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

468

2013

2.35

63.94

2.2

2.0

23.0

25.6

mg/l

0.45

152

521

(3007461) Platelets [#/volume] in Blood

22633

220502

2.01

63.12

30.6

18.0

263.0

255.8

e9/l

51.95

22302

215431

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

518

2340

2.24

63.06

1.4

1.5

—

(3022806) Fractional oxyhemoglobin in Capillary blood

482

2115

2.31

62.88

2.2

1.7

89.3

90.3

3.31

475

2083

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1924

12937

1.53

62.85

2.9

2.1

8.8

12.2

nmol/l

71.49

1654

11532

(3025468) Yersinia sp identified in Specimen by Organism specific culture

504

2260

2.26

62.46

1.4

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

509

2294

2.25

62.32

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

503

2264

2.25

61.78

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

503

2266

2.25

61.65

1.4

1.5

—

(3024928) Oxygen saturation in Venous blood

670

3371

2.02

61.63

4.2

3.5

—

(3035941) MCH [Entitic mass]

22639

220673

2.00

61.59

30.5

17.9

29.7

30.3

319.89

22444

218130

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

552

2585

2.16

61.46

1.2

1.3

0.1

0.2

nmol/l

2.98

157

(3024731) MCV [Entitic volume]

22638

220701

1.99

60.91

30.5

17.9

90.0

90.7

87.38

22444

218146

(3010813) Leukocytes [#/volume] in Blood

22643

220773

1.99

60.80

30.7

18.0

7.5

6.6

e9/l

307.65

22259

215163

(3026361) Erythrocytes [#/volume] in Blood

22639

220722

1.99

60.78

30.6

18.0

4.6

4.5

e12/l

59.78

22267

215146

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

392

1599

2.48

60.25

1.6

2.2

18.6

19.8

nmol/l

1.53

362

1524

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

550

2593

2.15

60.20

1.2

1.3

1.5

nmol/l

0.08

532

2498

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

503

2289

2.22

60.16

1.4

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1700

11228

1.55

60.14

2.4

2.2

5520.1

6066.4

u/l

0.35

621

4561

(3000963) Hemoglobin [Mass/volume] in Blood

22642

220802

1.99

60.11

30.8

18.1

134.8

135.7

g/l

17.56

22457

218268

(3035637) Corticotropin [Mass/volume] in Plasma

505

2305

2.22

59.95

1.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

169

424

4.01

59.63

1.7

1.2

17.6

16.7

umol/l

1.19

155

368

(3000570) Elastase.pancreatic [Mass/mass] in Stool

912

5136

1.81

59.52

1.4

283.6

280.9

ug/g

0.14

499

2890

(40761536) Microorganisms panel - Urine sediment

2356

16689

1.46

59.38

5.0

3.6

—

(21494755) Public health laboratory ask at order entry panel

1626

24126

0.65

59.25

1.3

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

684

3516

1.97

59.20

2.2

1.8

152.7

190.9

pmol/l

17.35

634

3349

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

505

2332

2.19

58.26

1.2

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

536

2542

2.13

57.79

1.1

1.5

g/l

0.35

478

2312

(3017732) Neutrophils [#/volume] in Blood

1968

13531

1.50

57.60

3.1

2.6

4.6

4.0

e9/l

16.30

1462

10907

(3012565) Volume of 24 hour Urine

251

833

3.04

57.51

2.4

2.1

1933.3

2021.0

0.63

230

757

(3020717) Zinc [Moles/volume] in Serum or Plasma

265

931

2.87

54.85

1.7

1.4

15.0

27.6

umol/l

15.80

257

891

(3020491) Glucose [Moles/volume] in Blood

343

1378

2.51

54.50

2.1

1.7

7.1

6.4

mmol/l

2.84

231

1032

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1014

6044

1.71

54.23

1.5

1.8

0.3

0.2

g/l

31.34

970

5742

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

222

710

3.15

54.22

2.0

2.1

222.7

88.0

ug/min

0.64

156

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5270

42954

1.29

53.95

1.7

1.6

—

(3004809) Band form neutrophils/100 leukocytes in Blood

543

2664

2.06

53.54

2.7

3.3

1.3

1.5

0.51

417

2092

(3017569) Oxygen content in Arterial blood

202

623

3.26

52.42

2.0

2.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

435

1988

2.21

51.52

1.4

12.1

11.6

mmol/l

0.38

118

376

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2854

21422

1.38

51.28

7.7

6.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2153

15395

1.44

51.20

1.2

125.2

148.0

iu/ml

1.78

778

5971

(3051387) C reactive protein [Mass/volume] in Capillary blood

687

3716

1.87

51.03

4.6

3.1

24.8

25.8

mg/l

0.28

466

2282

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1026

6251

1.67

50.51

1.5

1.8

1.3

1.2

g/l

61.26

982

5955

(46235355) HIV 1 and 2 tests - Meaningful Use set

5534

45723

1.28

50.23

1.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

722

4020

1.82

48.88

1.8

1.6

12945.4

12741.9

e6/l

0.04

529

2944

(3019977) pH of Arterial blood

234

819

2.88

48.83

2.7

2.5

7.4

0.70

263

(40761535) Cells panel - Urine sediment

1973

14036

1.44

48.09

4.0

3.3

—

(3048689) Calprotectin [Mass/mass] in Stool

3362

26118

1.34

48.06

2.4

145.9

121.8

ug/g

3.38

2639

20443

(3022145) Colonoscopy Study observation

2799

21149

1.37

48.01

1.4

1.3

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

134

335

4.02

47.60

1.5

1.4

5.6

nmol/l

0.03

127

317

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

2332

17148

1.40

47.15

2.7

2.5

35.2

43.8

u/l

1.08

1922

14817

(3003129) Base excess in Capillary blood by calculation

139

361

3.87

46.84

1.6

1.7

0.8

0.5

mmol/l

0.27

131

337

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

442

2117

2.11

46.50

1.7

1.5

56.2

54.6

0.34

276

1331

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

866

5156

1.71

46.46

2.2

2.1

10.8

10.6

mg/l

0.27

803

4826

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

299

1221

2.47

45.95

12.6

11.9

0.6

mmol/l

0.12

270

1128

(3000034) Microalbumin [Mass/volume] in Urine

340

1472

2.33

45.87

3.8

2.9

54.3

58.1

mg/l

0.11

265

1034

(3022621) pH of Urine by Test strip

1714

11987

1.46

45.63

3.4

2.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

316

1328

2.40

45.61

1.1

1.2

—

34.1

u/ml

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

633

3459

1.85

45.54

1.5

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

576

3062

1.90

45.15

1.7

1.4

7.4

6.9

mmol/l

2.85

421

2220

(3021788) Differential panel - Synovial fluid

577

3075

1.90

44.88

1.6

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

707

4023

1.78

44.52

1.5

1.7

—

(3044927) Protein electrophoresis panel - Urine

325

1399

2.34

44.44

1.3

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

946

5834

1.65

44.37

1.8

2.3

4.1

3.8

g/l

9.75

650

4240

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

947

5846

1.65

44.25

1.8

2.3

7.9

7.2

g/l

16.72

679

4465

(3044242) Glucose [Moles/volume] in Arterial blood

198

668

2.98

44.19

2.2

2.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

946

5840

1.65

44.19

1.8

2.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

578

3098

1.89

44.18

1.8

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

218

794

2.76

42.29

2.2

162.2

149.0

umol/l

0.19

115

392

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

328

1453

2.28

41.97

1.1

293.0

290.4

mg/l

0.25

281

1319

(3014271) Vancomycin [Susceptibility]

181

598

3.04

41.94

3.0

2.8

—

(3037756) Immunofixation for Serum or Plasma

565

3059

1.87

41.87

1.4

1.8

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

606

3380

1.81

40.82

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

605

3379

1.81

40.57

1.4

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

512

2719

1.90

40.29

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

342

1584

2.18

39.29

1.6

1.5

30.3

33.7

0.89

207

976

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

873

5448

1.63

39.04

1.8

2.3

10.3

10.2

g/l

0.15

745

4612

(3001556) Androgen free Index in Serum or Plasma

221

4.36

38.12

1.3

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

669

3920

1.73

38.04

1.5

1.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

5222

44013

1.24

37.96

4.2

3.3

—

(3000492) Spirometry study

2501

19207

1.34

37.96

1.5

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

370

1798

2.07

37.55

2.8

3.7

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

436

2253

1.95

37.25

1.8

1.6

8.5

7.4

mmol/l

13.95

274

1358

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

509

2780

1.85

36.73

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

241

994

2.44

36.36

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

238

976

2.45

36.36

1.3

1.4

—

(3047181) Lactate [Moles/volume] in Blood

845

5342

1.60

35.82

7.9

5.6

1.4

1.3

mmol/l

3.79

770

4701

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

971

6358

1.55

35.36

1.7

1.9

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

126

374

3.38

34.93

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

129

391

3.31

34.60

1.2

338.0

354.1

pmol/l

0.10

295

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

197

759

2.61

34.33

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

197

759

2.61

34.33

1.3

1.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

155

529

2.94

34.02

1.2

—

(3004451) EKG impression Narrative

183

685

2.68

33.78

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

860

5542

1.57

33.60

1.9

2.4

3.1

3.0

g/l

2.44

666

4365

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

507

2857

1.79

33.06

1.5

1.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

474

2626

1.82

32.71

6.2

5.2

349.9

372.8

umol/l

2.99

418

2286

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

271

1236

2.21

32.44

18.6

17.6

4141.7

2216.7

nmol/l

0.31

260

1185

(3045424) Erythrocytes [Presence] in Urine

550

3194

1.74

32.33

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1191

8289

1.46

32.27

1.3

0.2

1.1

u/ml

8.39

133

689

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

260

1174

2.23

31.90

13.4

12.6

835.0

838.8

nmol/l

0.05

249

1137

(40768441) Liver Pathology biopsy report

288

1355

2.14

31.89

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

825

5334

1.57

31.78

2.5

2.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

895

5904

1.54

31.51

2.6

2.7

4.0

3.5

g/l

16.89

855

5606

(3016650) Hepatitis A virus Ab [Presence] in Serum

551

3226

1.73

31.47

1.1

—

(3006270) Folate [Moles/volume] in Blood

288

1368

2.12

31.12

1.2

1.1

368.9

375.3

nmol/l

0.20

219

1217

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

452

2511

1.82

30.93

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

646

3977

1.64

30.53

2.6

2.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1585

21145

0.73

30.50

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

439

2429

1.82

30.45

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

165

619

2.68

30.38

2.5

2.4

—

(40768804) Tissue Pathology biopsy report

8867

79853

1.18

30.27

2.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

997

14355

0.68

30.03

1.4

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

627

3848

1.65

30.00

3.1

3.4

4.7

4.0

e9/l

10.75

627

3842

(3022689) Creatine [Moles/volume] in Urine

138

479

2.89

29.45

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

771

4996

1.56

29.42

2.0

2.5

0.5

0.8

g/l

3.48

667

4342

(4034850)

886

5919

1.52

29.41

10.7

8.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

313

1568

2.01

29.33

1.5

1.4

124690.1

99960.9

e6/l

0.24

230

1065

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

507

2967

1.72

29.03

1.5

—

(3036489) Thrombin time

1054

7313

1.46

29.00

2.0

2.1

21.4

21.3

0.04

873

6309

(3023511) Choriogonadotropin [Units/volume] in Urine

861

5737

1.52

28.93

1.4

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

394

2146

1.85

28.77

1.4

—

(3044941) Cell count panel - Synovial fluid

448

2555

1.77

28.11

1.5

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

303

1526

2.00

28.00

3.3

2.8

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

440

2501

1.77

27.93

2.8

2.6

463.0

734.1

u/ml

0.19

423

2340

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

220

985

2.25

27.63

1.1

7.4

10.6

u/ml

0.63

169

(3052851) Hemolysis interference index of Serum or Plasma

791

5267

1.52

26.68

3.4

3.1

—

(37021550) Renin [Units/volume] in Plasma --upright

110

356

3.10

26.60

1.3

110.7

92.3

mu/l

0.23

269

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

256

1237

2.08

26.53

1.7

1.4

5.6

5.5

mmol/l

0.78

239

1170

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

285

1443

1.99

25.98

1.3

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

285

1443

1.99

25.98

1.3

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

285

1443

1.99

25.98

1.3

1.8

—

(3038026) Centromere Ab [Units/volume] in Serum

298

1534

1.95

25.90

1.2

46.9

49.5

u/ml

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

226

1051

2.16

25.88

1.4

1.5

17.3

22.5

u/ml

1.25

214

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

345

1868

1.86

25.73

1.2

58.0

62.3

u/l

0.48

231

1246

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

242

1159

2.10

25.69

1.3

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

316

1664

1.91

25.68

2.6

3.3

60.0

57.3

1.24

200

1093

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1221

8905

1.39

25.44

2.5

2.3

—

(3042631) Mycobacterium sp identified in Specimen

377

2106

1.80

25.42

2.3

2.7

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

399

2275

1.77

25.11

1.2

1.1

2.1

iu/ml

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

404

2316

1.76

24.95

1.5

1.4

—

(3036603) Volume of Urine

243

1183

2.07

24.72

1.6

1973.7

2035.1

0.20

246

(3002256) Pathology report gross observation

3007

24890

1.24

24.51

1.2

1.3

—

(3039000) Anion gap in Blood

584

3707

1.59

24.41

9.4

6.6

11.4

11.2

mmol/l

0.97

539

3321

(3018572) Chloride [Moles/volume] in Blood

584

3708

1.59

24.39

9.4

6.6

105.2

105.3

mmol/l

0.14

539

3322

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

9.37

24.38

5.0

6.4

0.2

mmol/l

0.31

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

288

1500

1.93

24.22

1.2

77.0

62.1

u/ml

0.32

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

690

4562

1.53

24.08

1.8

2.3

36.5

38.3

g/l

11.09

598

3969

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

288

1504

1.93

24.03

1.2

62.7

43.6

u/ml

0.48

117

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

680

4489

1.53

23.90

1.9

2.3

0.0

g/l

3.23

626

4104

(40768443) Skin Pathology biopsy report

1103

7991

1.40

23.90

1.2

—

(44806420)

105

353

2.98

23.82

2.1

2.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

391

2256

1.75

23.64

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

278

3.25

23.57

3.0

2.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

104

350

2.98

23.56

1.4

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

896

6271

1.45

23.56

2.1

2.3

93.1

92.4

0.42

823

5816

(3034891) Synovial lining cells/100 cells in Synovial fluid

184

819

2.26

23.52

1.5

5.1

3.6

0.65

184

(3003338) MCHC [Mass/volume]

16577

172853

0.86

23.27

25.5

15.4

329.9

332.9

g/l

291.95

16455

171697

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

513

3197

1.62

23.17

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

143

573

2.50

23.16

2.2

2.0

3878.8

2321.3

e6/l

0.18

390

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

885

6210

1.44

22.95

1.7

1.6

2.3

7.3

iu/ml

0.65

186

1261

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

14936

141571

1.15

22.78

3.5

3.3

—

(3023419) Bacteria identified in Sputum by Culture

356

2030

1.77

22.45

2.4

2.5

—

(3032057) Clostridioides difficile [Presence] in Stool

324

3.00

22.29

2.0

1.8

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

274

1446

1.91

22.20

1.2

6.6

8.2

u/ml

0.17

109

(3049717) Cytology report of Urine Cyto stain

807

5606

1.46

22.09

2.3

2.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

129

504

2.57

22.04

2.2

1.8

8184.5

11414.0

e6/l

0.28

263

(3026692) Albumin [Mass/volume] in Peritoneal fluid

109

394

2.77

21.72

1.5

1.4

13.5

13.1

g/l

0.14

291

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1449

11116

1.32

21.71

2.8

3.2

39.1

45.8

u/ml

0.69

1384

10740

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

242

1234

1.97

21.71

1.6

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

976

7043

1.40

21.64

1.2

1.3

—

(3033799) Differential panel - Peritoneal fluid

127

498

2.56

21.55

2.3

1.9

—

(36660697) Celiac disease serology panel - Serum

2071

16662

1.27

21.53

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

224

3.40

21.48

5.7

5.5

—

(3011288) Drugs identified in Urine by Screen method

900

6417

1.42

21.38

2.6

2.9

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

182

841

2.17

21.28

1.7

1.8

2.0

umol/l

1.40

176

786

(21494890) Protein electrophoresis panel - 24 hour Urine

287

1562

1.85

21.15

1.5

2.2

—

(1761868) Lipid panel - Serum or Plasma

8161

74430

1.15

21.08

3.7

2.5

—

(4306422)

497

3182

1.57

20.10

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

618

4150

1.50

20.09

1.9

2.4

0.0

g/l

0.11

565

3777

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

151

662

2.29

20.09

1.3

1.4

13.1

14.9

pmol/l

3.42

124

555

(3045414) Leukocytes [Presence] in Urine

1141

8550

1.35

20.05

1.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

495

3172

1.57

19.95

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

143

615

2.33

19.90

12.1

9.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

248

1316

1.89

19.82

1.1

ratio

0.24

483

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

630

4279

1.49

19.39

1.5

1.4

12.8

21.8

u/ml

2.01

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

144

629

2.30

19.35

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

118

472

2.51

19.27

3.4

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

118

472

2.51

19.27

3.4

2.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

606

4094

1.49

19.15

1.9

2.4

0.0

g/l

0.00

559

3769

(3023323) Follitropin [Units/volume] in Serum or Plasma

1599

12640

1.28

19.13

1.4

1.3

19.7

27.3

iu/l

26.16

1338

10963

(3037556) Urate [Mass/volume] in Serum or Plasma

116

462

2.52

19.12

1.4

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

753

5309

1.43

19.07

1.3

4.3

8.8

u/ml

3.58

106

850

(3002331) Protein [Mass/volume] in Peritoneal fluid

339

2.78

18.87

1.5

1.4

26.3

29.5

g/l

0.31

260

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

711

4973

1.44

18.81

1.4

132.9

117.4

pmol/l

0.45

681

4849

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

265

3.03

18.73

3.9

5.3

70.7

40.4

ug/min

2.02

198

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

917

6715

1.38

18.65

2.1

1.7

—

(40757494) Bilirubin.total [Moles/volume] in Blood

181

885

2.05

18.35

2.3

2.2

17.8

32.1

umol/l

1.13

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

345

2.73

18.27

1.3

1.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

628

4315

1.47

18.25

1.5

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

620

4253

1.47

18.18

1.2

3.4

4.5

u/ml

0.22

321

(3045716) Anion gap in Serum or Plasma

152

698

2.19

18.14

2.3

2.5

9.3

9.2

mmol/l

0.06

117

502

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

612

4190

1.47

18.12

1.2

14.2

18.0

u/ml

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

180

883

2.05

18.09

1.4

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

180

883

2.05

18.09

1.4

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

180

883

2.05

18.09

1.4

2.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

803

5782

1.40

18.07

1.3

32.2

35.0

u/ml

0.07

370

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

737

5228

1.42

18.06

1.3

7.9

6.1

u/ml

0.27

553

(40762365) Oxygen content in Arterial blood by calculation

240

3.09

17.98

2.5

3.0

14.9

ml/dl

0.05

227

(3000093) Morphology [Interpretation] in Blood Narrative

277

1571

1.77

17.91

1.2

1.1

—

(4024509)

281

1601

1.76

17.88

1.8

1.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

128

552

2.33

17.76

7.9

6.2

25.9

25.0

mmol/l

1.25

118

506

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2029

16637

1.24

17.74

1.4

1.5

—

(3002385) Erythrocyte distribution width [Ratio]

17317

166879

1.15

17.71

24.0

14.8

14.0

13.5

265.44

17078

163605

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

232

3.11

17.70

16.5

9.2

5.5

5.3

mmol/l

0.21

232

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

179

885

2.03

17.63

1.4

2.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

181

901

2.02

17.50

1.2

1.3

43.8

68.5

titre

1.03

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

315

1866

1.70

17.46

1.6

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

304

2.80

17.37

2.0

2.8

117.1

28.0

mg/l

1.20

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

185

931

2.00

17.35

1.2

1.3

354.3

362.4

titre

0.02

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

801

5816

1.39

17.17

2.5

199.4

180.7

7.38

763

5512

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

183

924

1.99

17.01

1.1

20.0

26.1

u/l

0.92

140

728

(43055442) Apixaban [Mass/volume] in Serum or Plasma

158

3.55

17.00

1.6

1.5

110.5

116.1

ug/l

0.13

134

(3017315) Amylase [Enzymatic activity/volume] in Urine

197

1021

1.94

16.98

1.3

1.2

257.9

355.9

u/l

0.90

184

941

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

220

1191

1.86

16.62

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

182

927

1.97

16.52

1.1

79.8

85.9

u/l

0.61

147

749

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1803

14709

1.24

16.48

3.2

2.5

61.9

70.3

ml/min/173m2

13.98

878

5482

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

466

3078

1.52

16.47

1.1

124.6

117.6

4.47

415

2796

(3034274) Bile acid [Moles/volume] in Serum --fasting

539

3675

1.48

16.34

2.0

2.2

5.2

6.6

umol/l

2.12

398

2669

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

156

756

2.07

16.26

3.3

3.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

268

1552

1.74

16.17

1.1

1.2

160.3

190.0

titre

0.25

277

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

361

2.55

15.73

3.2

2.5

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

265

1550

1.72

15.45

1.1

1.2

285.7

125.6

titre

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

117

3.85

15.40

1.5

1.9

47.6

44.8

umol/l

0.24

117

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

252

1455

1.74

15.39

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

569

3977

1.44

15.19

1.5

107.9

112.3

u/ml

0.55

144

874

(3027135) IgG subclass 1 [Mass/volume] in Serum

329

2046

1.62

15.17

1.3

1.4

6.4

6.8

g/l

1.30

229

1420

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3214

27926

1.18

15.07

2.1

2.0

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

476

3221

1.49

15.02

1.3

1.6

0.7

g/l

0.60

362

2419

(4062490)

329

2055

1.61

14.91

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

327

2045

1.61

14.75

1.3

1.4

2.8

3.0

g/l

0.69

230

1417

(3024139) IgG subclass 3 [Mass/volume] in Serum

327

2045

1.61

14.75

1.3

1.4

0.4

g/l

0.13

229

1420

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

154

3.38

14.72

2.0

2.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

315

2.61

14.67

3.6

2.2

8.2

7.6

mmol/l

0.46

184

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

181

960

1.89

14.64

1.1

101.0

95.4

1.53

138

778

(1001926) Buprenorphine [Presence] in Urine by Screen method

956

7316

1.32

14.60

2.1

2.2

—

(3044007) Cell count panel - Peritoneal fluid

107

468

2.29

14.47

2.5

1.9

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

186

3.12

14.45

1.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

139

677

2.06

14.36

1.7

2.5

0.7

1.2

ug/l

4.07

126

645

(3020191) Ethanol [Moles/volume] in Serum or Plasma

268

1605

1.68

14.36

1.6

1.4

1.3

1.4

promille

0.41

209

1219

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

602

4299

1.41

14.29

1.2

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

225

1289

1.75

14.17

2.1

1.9

2.5

1.9

u/field

0.62

595

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

160

830

1.93

13.86

1.4

460.5

736.1

mu/l

1.19

152

794

(3011648) Oxygen content in Venous blood

228

1323

1.73

13.74

2.7

11.4

11.2

0.43

228

1323

(3042733) HLA Ab [Presence] in Serum

135

663

2.04

13.67

4.9

5.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

240

1418

1.70

13.56

1.1

—

(4015189)

419

2.32

13.53

2.5

2.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

277

1704

1.63

13.41

1.5

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

603

4363

1.39

13.29

1.2

1.3

4.1

3.7

mmol/l

14.68

564

4111

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

422

2872

1.48

13.01

1.3

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

160

849

1.89

12.99

1.3

1.4

72.8

72.7

0.02

152

813

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

563

4047

1.40

12.91

1.3

284.4

265.6

u/ml

0.79

333

2648

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

342

2.43

12.89

1.1

1.2

0.6

77.7

mg/l

2.13

257

(3008898) HLA-B27 [Presence]

1006

7888

1.29

12.85

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

165

892

1.86

12.65

1.9

2.4

21.8

208.6

ug/l

1.55

156

851

(3003181) Sodium [Moles/volume] in Urine

386

2608

1.49

12.37

1.3

1.4

62.4

64.4

mmol/l

0.37

279

2083

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

175

971

1.81

12.35

1.6

1.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1282

10397

1.25

12.35

1.1

184.8

219.9

titre

0.14

265

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

458

3201

1.44

12.32

1.3

1.2

4.6

3.8

u/ml

0.52

201

1430

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

135

690

1.96

12.28

1.4

2.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

665

4954

1.35

12.26

1.2

1.4

557.9

508.1

mg/l

0.52

627

4742

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

260

1612

1.62

12.24

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

189

2.91

12.22

2.0

—

(40768446) Kidney Pathology biopsy report

144

754

1.92

12.20

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

293

1872

1.57

12.17

1.4

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

639

8530

0.74

12.15

1.5

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

263

2.59

12.08

1.1

—

(44813793)

248

1525

1.63

12.08

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

469

3307

1.43

12.04

1.3

1.2

3.9

3.7

u/ml

0.08

159

1142

(3035320) C reactive protein [Mass/volume] in Body fluid

227

1367

1.67

12.00

3.3

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

134

690

1.95

11.94

1.4

2.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1256

10207

1.24

11.89

1.5

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

277

2.53

11.88

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

156

848

1.85

11.79

1.2

1.1

3.7

3.6

iu/ml

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

135

701

1.93

11.75

1.5

2.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1058

8453

1.26

11.63

1.1

1.0

13.0

u/ml

1.53

115

(3019832) Treponema pallidum Ab [Presence] in Serum

3095

27334

1.15

11.51

1.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

160

884

1.82

11.49

1.7

1.6

6.2

5.6

mmol/24h

0.19

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

535

3892

1.38

11.48

5.2

6.0

787.4

1430.6

iu/ml

0.62

577

(3014765) Yersinia sp identified in Stool by Organism specific culture

752

5764

1.31

11.43

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

465

2.13

11.36

1.5

1.3

85.1

126.1

nmol/l

2.32

348

(3024263) Appearance of Synovial fluid

157

866

1.82

11.34

1.9

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

137

724

1.90

11.33

3.5

4.0

—

(3000012) Reticulocyte production index

156

860

1.82

11.30

1.2

1.4

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

192

1126

1.71

11.24

1.5

1.6

7.7

6.1

u/l

0.38

545

(3039443) Prostate specific Ag panel - Serum or Plasma

197

3241

0.60

11.20

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

751

5775

1.31

11.16

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

138

736

1.88

11.11

6.3

5.3

2891.5

2378.6

mg/l

0.09

550

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

184

1072

1.72

11.04

1.2

1.1

42.0

10.3

u/ml

—

121

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

743

5714

1.31

11.03

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3600

40109

0.88

11.03

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

215

1307

1.65

11.01

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

422

2971

1.43

10.97

1.5

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3482

31099

1.14

10.96

2.2

2.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

215

1314

1.64

10.79

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

511

6923

0.73

10.76

1.6

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

553

4095

1.36

10.66

1.2

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

100

484

2.07

10.64

1.4

1.2

37.4

39.6

g/l

0.70

251

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

179

1047

1.72

10.61

1.2

1.3

76.2

86.3

u/l

1.02

156

910

(44806118)

298

1973

1.52

10.61

1.5

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5338

49008

1.12

10.61

4.5

4.7

2.3

2.9

ug/l

0.97

4688

44402

(44790048)

298

1974

1.52

10.58

1.5

1.6

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

101

492

2.06

10.57

1.5

1.3

55.1

51.8

0.38

420

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

175

1019

1.72

10.55

1.2

1.3

21.3

21.0

u/l

0.03

147

872

(3043238) Trisomy 21 risk [Likelihood] in Fetus

528

7093

0.74

10.52

1.6

1.5

—

(44806071)

270

2.45

10.50

1.1

—

(44790049)

297

1973

1.51

10.42

1.5

1.6

—

(44790047)

297

1974

1.51

10.39

1.5

1.6

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

168

2.86

10.38

1.1

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

213

2.63

10.35

2.8

2.6

0.9

1.2

mmol/l

0.56

149

(3005033) Fetal Nuchal fold Thickness US

514

6913

0.74

10.33

1.6

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

781

6104

1.29

10.30

1.1

4.3

5.6

u/ml

0.58

886

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1355

11269

1.21

10.29

1.1

—

(40768800) Prostate Pathology biopsy report

191

3083

0.62

10.08

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

5.81

10.05

1.2

1.1

89.1

111.2

nmol/24h

0.57

(3019420) Tryptase [Mass/volume] in Serum or Plasma

188

1138

1.66

9.84

1.2

1.5

6.7

8.2

ug/l

1.22

168

1030

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

132

723

1.83

9.83

2.8

2.7

—

(3001729) Color of Synovial fluid

115

3.22

9.81

1.6

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

228

1449

1.58

9.80

1.3

1.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

142

2.96

9.68

2.5

2.0

66.1

59.8

0.47

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

226

1440

1.58

9.61

1.3

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

121

650

1.87

9.60

2.6

2.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

416

2997

1.40

9.55

2.3

3.0

574.4

7376.9

u/ml

1.05

151

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

295

2.31

9.54

5.5

5.7

65.8

70.7

0.76

227

(3017704) Immunofixation for Urine

141

799

1.77

9.41

1.2

1.7

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

128

706

1.82

9.35

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

527

3962

1.34

9.25

1.7

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

120

651

1.85

9.25

1.4

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

195

1213

1.61

9.20

2.2

2.1

98.9

97.8

0.19

181

1121

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

150

873

1.72

9.13

1.7

1.5

—

(3016879) Cocaine [Presence] in Urine

1068

8782

1.23

9.11

2.1

—

(3025315) Body weight

148

2.84

9.02

5.4

4.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

221

1424

1.56

8.99

1.2

—

(40762814) Titanium [Mass/volume] in Blood

229

2.45

8.98

2.3

2.4

3.6

3.7

ug/l

0.04

(3003434) Protein [Mass/volume] in Pleural fluid

267

1794

1.49

8.94

1.5

33.3

33.9

g/l

0.30

246

1629

(3023199) Leukocytes [#/volume] in Pleural fluid

244

1610

1.52

8.91

1.5

3317.9

3118.3

e6/l

0.05

189

1159

(3025549) Creatine [Moles/time] in 24 hour Urine

128

2.97

8.84

1.4

—

14.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

572

4381

1.31

8.84

1.4

1.5

1428.1

2667.4

e6/l

0.57

478

3567

(3043410) Blood group antigens tested for on Red Blood Cells

485

1.96

8.81

1.7

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

571

4375

1.31

8.80

1.3

1.4

63.3

24.4

e6/l

0.84

450

3385

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

612

4743

1.30

8.68

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

226

1477

1.54

8.65

1.2

1.3

0.9

1.1

u/ml

0.16

103

625

(3000764) Benzodiazepines [Presence] in Urine

1139

9484

1.21

8.59

2.1

2.0

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

3.24

8.59

1.7

0.6

0.7

0.09

(3024932) HLA-DR beta [Type]

119

663

1.80

8.46

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

207

1334

1.56

8.45

1.6

1.4

67.3

70.0

umol/l

0.36

104

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

232

1534

1.52

8.42

1.1

1.3

2.1

2.0

mmol/l

0.85

215

1440

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

179

1117

1.61

8.38

1.0

1.1

3.3

6.8

nmol/l

0.77

225

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

111

3.07

8.36

2.5

2.1

11.6

16.4

0.61

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

250

1683

1.49

8.33

1.2

1.4

—

(3027008) Opiates [Presence] in Urine

1142

9541

1.21

8.32

2.1

2.0

—

(3028300) Cannabinoids [Presence] in Urine

1143

9566

1.20

8.18

2.1

2.0

—

(3024471) HLA-A [Type]

120

678

1.77

8.15

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

148

887

1.67

8.14

1.7

1.5

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

4.42

7.88

1.4

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

113

635

1.78

7.84

1.1

2.6

7.9

u/ml

0.49

373

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

237

1605

1.48

7.71

1.8

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

293

2066

1.42

7.71

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

1008

0.43

7.66

1.6

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

315

2258

1.40

7.56

1.2

1.1

97.9

94.4

1.42

296

2121

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1624

14108

1.16

7.51

2.4

2.3

24.4

22.8

au/ml

0.17

959

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

659

5257

1.26

7.47

1.8

1.9

3.9

14.0

iu/l

1.32

221

2047

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

131

780

1.68

7.43

1.1

1.2

0.3

g/l

3.06

109

629

(3008295) Osmolality of Serum or Plasma

244

1677

1.46

7.39

1.5

285.3

280.4

mosm/kgh2o

2.48

186

1321

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

122

715

1.71

7.34

1.1

1.2

110.5

111.0

0.08

109

644

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

310

2.10

7.34

1.5

1.4

24.4

22.9

0.16

260

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

254

1764

1.44

7.29

1.3

1.5

—

(3011412) CD3 cells [#/volume] in Blood

271

1907

1.43

7.24

2.1

2.6

1.3

1.2

e9/l

1.05

152

1138

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.82

7.23

1.8

2.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

648

5183

1.26

7.20

1.2

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

150

2.60

7.17

1.4

1.3

0.8

1.8

ml/s/173m2

1.31

101

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1496

12968

1.16

7.12

1.3

29.9

47.3

au/ml

2.31

565

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

219

3176

0.69

7.07

2.9

3.6

20.5

34.1

u/ml

4.13

207

3064

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

390

1.95

7.04

1.4

1.6

0.4

ug/l

0.50

266

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

453

3477

1.31

7.00

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

843

6973

1.22

6.87

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

18829

184893

1.10

6.87

20.4

13.1

39.5

40.0

7.63

12819

142383

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

754

6169

1.23

6.84

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

150

947

1.59

6.79

1.6

1.7

2.7

2.4

u/field

0.14

104

687

(3010503) CD19 cells [#/volume] in Blood

175

1145

1.53

6.77

2.4

2.7

0.2

0.3

e9/l

0.68

169

1117

(3028308) Erythrocytes [#/volume] in Pleural fluid

215

1469

1.47

6.75

1.5

90425.9

47998.7

e6/l

1.00

126

872

(4198724)

158

1012

1.57

6.73

2.0

2.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

118

705

1.68

6.66

1.1

1.0

5.5

11.3

u/ml

1.71

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

110

2.82

6.66

1.3

1.2

122.4

98.2

ug/l

0.42

(4281824)

286

2064

1.39

6.66

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

108

631

1.71

6.62

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

435

1.87

6.58

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

124

758

1.64

6.43

1.1

—

(3047189) Immunofixation for 24 hour Urine

117

706

1.66

6.38

1.5

1.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

393

3003

1.31

6.32

1.8

2.0

3.3

6.1

titre

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

108

2.78

6.29

1.9

1.3

356.4

301.8

umol/24h

0.62

108

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

204

1403

1.46

6.24

2.2

2.7

531.9

510.6

e6/l

0.29

181

1168

(4211845)

153

993

1.54

6.19

3.4

2.7

—

(3035880) pH of Pleural fluid

120

736

1.63

6.16

1.2

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

182

1228

1.49

6.14

1.7

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

461

1.80

6.09

1.5

1.9

21.3

32.3

u/l

0.73

412

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

198

1362

1.46

6.06

2.2

2.7

0.2

e9/l

0.14

180

1168

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

102

603

1.69

6.04

2.9

3.3

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

370

1.89

6.01

1.3

27.4

23.3

0.53

338

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.24

5.98

1.2

1.4

502.6

517.8

nmol/l

0.04

(3004716) Salmonella sp identified in Stool by Organism specific culture

1296

11277

1.16

5.91

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

156

1028

1.52

5.91

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

394

1.86

5.89

1.2

1.1

—

(3002619) Bacteria identified in Specimen by Culture

373

1.88

5.87

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

118

731

1.62

5.85

1.7

2.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

270

2.04

5.84

1.4

1.3

—

(3027944) Amphetamines [Presence] in Urine

1093

9397

1.17

5.83

2.0

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

360

1.89

5.82

1.1

1.0

0.8

umol/24h

0.20

182

(3026250) Tacrolimus [Mass/volume] in Blood

140

904

1.55

5.82

36.0

35.5

7.3

7.4

ug/l

0.17

124

825

(3006462) Nitrate [Presence] in Urine

140

905

1.55

5.80

3.6

2.8

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

212

1491

1.43

5.79

1.6

2.2

12.9

13.8

0.49

727

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

433

3397

1.28

5.75

2.7

3.6

644.1

785.5

u/ml

0.16

388

3109

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

4.24

5.55

1.3

1.0

1.4

u/field

0.63

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

178

1223

1.46

5.53

1.4

1.3

450.5

506.1

u/l

0.29

167

1165

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

193

1350

1.43

5.46

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

865

7339

1.19

5.44

1.7

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

545

4426

1.24

5.40

1.2

37.7

43.3

u/ml

0.31

446

(3025018) Bordetella pertussis Ab [Titer] in Serum

180

1246

1.45

5.39

1.2

—

(40768793) Breast Pathology biopsy report

361

4616

0.78

5.23

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

156

1058

1.48

5.20

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

235

2.04

5.18

1.8

3.3

—

(3029612) Listeria sp Ab [Titer] in Serum

3.47

5.16

1.2

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

170

2.24

5.14

8.7

7.4

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.79

5.12

1.0

0.0

0.1

u/ml

0.89

(3051651) Icteric interference index of Serum or Plasma

158

1081

1.46

5.05

3.6

3.7

—

(3025577) Chromium [Mass/volume] in Blood

131

863

1.52

5.04

2.1

2.4

2.3

ug/l

0.08

107

721

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1910

17231

1.12

5.02

3.3

4.1

19.9

24.5

ug/l

0.32

1522

13577

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

679

5684

1.20

5.00

1.2

—

(3025130) Human papilloma virus identified in Specimen

282

3698

0.76

4.98

1.6

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

163

1127

1.45

4.95

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

316

1.87

4.94

1.4

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

342

2659

1.29

4.94

2.3

2.5

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

267

1.95

4.94

1.2

1.5

1.8

mmol/l

0.71

164

(3048879) Bone marrow aspiration report

434

1.73

4.88

1.4

2.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

145

984

1.48

4.85

1.4

1.6

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

436

1.72

4.81

8.3

8.8

—

(3026470) Cobalt [Mass/volume] in Blood

133

890

1.50

4.78

2.1

2.0

5.2

3.3

ug/l

1.09

114

782

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

3.41

4.74

10.4

7.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

191

1373

1.39

4.70

1.1

7.1

8.1

iu/ml

0.42

347

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

384

3050

1.26

4.69

1.1

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

243

1816

1.34

4.69

3.5

3.3

—

(3036180) Methadone [Presence] in Urine

3.69

4.64

2.1

2.3

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

139

946

1.47

4.61

2.3

2.0

203.0

196.4

u/l

0.61

139

938

(3016038) Potassium [Moles/volume] in Urine

144

988

1.46

4.59

1.2

1.3

30.3

35.0

mmol/l

1.97

118

866

(3016018) Differential panel - Cerebral spinal fluid

280

2144

1.31

4.57

1.3

1.5

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

254

1.93

4.55

10.6

7.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.97

4.54

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

122

812

1.51

4.52

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

888

7683

1.16

4.46

1.9

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

493

1.65

4.41

1.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

535

1.61

4.31

1.7

1.6

11.6

8.6

ug/l

4.76

535

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

288

1.84

4.30

1.2

1.1

0.0

0.2

u/ml

1.12

176

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.90

4.16

1.1

187.5

208.6

pmol/l

0.12

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

208

1.97

4.09

1.1

1.3

—

60.8

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

122

2.30

4.09

1.4

1.3

25.1

21.6

mmol/l

1.95

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.08

4.07

1.1

1.2

—

mmol/l

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

623

1.54

4.04

1.4

1.5

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

3.33

4.03

11.7

6.5

45.1

51.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

111

744

1.49

4.03

2.2

2.8

178.0

162.2

au/ml

0.13

105

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

476

1.62

3.99

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

105

2.38

3.96

1.1

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

170

2.06

3.94

1.5

1.2

5.3

5.9

mmol/l

0.25

(3047007) Chlamydophila sp Ab [Presence] in Serum

392

3191

1.23

3.93

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

389

3165

1.23

3.92

1.1

—

(3001218) Citrate [Mass/time] in 24 hour Urine

4.17

3.88

1.4

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

120

824

1.46

3.88

2.4

2.5

54.8

52.7

umol/l

0.25

706

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

385

3133

1.23

3.87

1.1

—

(3012441) Differential panel - Pleural fluid

187

1389

1.35

3.84

1.6

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

389

1.67

3.83

8.6

8.7

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

126

2.22

3.81

1.0

0.1

0.6

u/ml

1.44

114

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

235

1.87

3.80

1.1

1.0

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

109

738

1.48

3.79

1.8

2.0

7.2

9.6

mg/l

5.10

597

(3045788) Cell count panel - Pleural fluid

171

1257

1.36

3.76

1.6

1.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

369

3002

1.23

3.74

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

694

5982

1.17

3.73

2.8

3.6

1449.6

1542.1

u/ml

0.03

571

5146

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

493

1.58

3.72

1.3

1.4

58.4

61.8

0.38

413

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

652

1.51

3.72

1.6

1.8

5560.9

28689.5

u/ml

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.57

3.70

1.0

0.0

0.1

u/ml

0.85

(3036782) Glucose [Moles/volume] in Pleural fluid

181

1348

1.35

3.67

1.3

6.8

6.2

mmol/l

2.20

164

1241

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

248

1935

1.28

3.61

1.7

2.0

25.1

23.8

ug/l

0.09

243

1894

(3011436) Histone Ab [Units/volume] in Serum

412

1.63

3.58

1.1

—

37.7

u/ml

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.35

3.56

1.0

1.1

34.4

65.9

u/l

1.31

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

307

2467

1.25

3.51

1.2

1.3

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

116

809

1.44

3.50

2.7

3.4

8.2

8.0

mg/l

0.10

646

(3042517) Benzodiazepines panel - Urine

279

1.76

3.48

2.7

2.5

—

(4268621)

284

2265

1.26

3.47

2.4

2.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1696

15523

1.10

3.45

1.5

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

640

1.49

3.43

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

135

972

1.39

3.41

1.4

1.3

12.6

13.5

u/l

0.28

125

902

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

110

765

1.44

3.38

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

209

1.87

3.37

1.2

1.3

0.8

1.7

mmol/l

1.15

138

(3020393) Adenovirus Ag [Presence] in Stool

188

1.92

3.36

1.0

1.3

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

253

1.78

3.35

1.3

57.8

53.6

0.18

122

(3011325) HIV 1+2 Ab [Presence] in Serum

101

2.28

3.35

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

139

1011

1.38

3.32

1.8

2.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

500

1.54

3.31

1.2

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

670

1.46

3.30

1.2

0.1

0.2

g/l

—

(3010375) cycloSPORINE [Mass/volume] in Blood

121

861

1.41

3.29

28.1

27.8

112.6

117.2

ug/l

0.30

715

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

255

2023

1.26

3.28

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

415

1.59

3.26

1.3

1.4

1.5

2.9

1.42

356

(3044009) aPTT.lupus sensitive (LA screen)

198

1.87

3.23

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

385

1.61

3.23

1.2

1.3

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

584

1.49

3.22

1.7

199.3

123.5

au/ml

0.61

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1070

0.65

3.21

1.2

1.3

—

(40758358) Immune stain study

2.44

3.20

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

3.57

3.19

1.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

137

1002

1.37

3.18

1.3

42.1

66.8

1.85

112

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.96

3.13

1.0

1.6

—

(3003740) Influenza virus B Ag [Presence] in Specimen

312

3804

0.82

3.13

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.41

3.13

1.1

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

198

1533

1.29

3.12

1.5

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

173

1.91

3.08

1.0

1.1

38.9

45.4

mg/l

—

(40757373) Influenza virus identified in Isolate

337

1.63

3.04

1.7

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

123

893

1.38

3.01

1.1

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

105

1465

0.72

2.98

1.0

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

543

4683

1.16

2.98

1.3

—

(3000219) Insulin receptor Ab [Presence] in Serum

10.00

2.98

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

314

3803

0.82

2.96

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

223

1766

1.27

2.96

1.0

1.1

233.6

248.8

mg/l

0.60

195

1550

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

482

1.52

2.95

1.1

—

(4094501)

574

4976

1.16

2.95

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

489

4190

1.17

2.92

1.1

4.1

5.3

u/ml

1.12

252

2153

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

159

1207

1.32

2.92

1.5

2.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

319

2632

1.21

2.91

1.3

16.0

58.3

u/ml

5.64

187

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

229

1824

1.26

2.90

1.1

1.2

43.3

40.0

mg/l

0.49

195

1528

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

190

1481

1.29

2.88

3.3

3.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

115

2.09

2.87

1.2

1.1

10.2

10.5

u/l

0.03

115

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

182

1412

1.29

2.86

1.7

2.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

617

1.44

2.84

1.3

1.2

28.9

21.2

0.32

(3002621) Streptococcal DNAse B [Units/volume] in Serum

171

1.87

2.84

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

466

3988

1.17

2.84

1.1

0.8

1.2

u/ml

0.78

191

1679

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

538

4659

1.16

2.82

1.1

1.5

1.7

u/ml

0.14

238

1848

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

488

1.50

2.80

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

140

1051

1.33

2.79

1.8

150.7

136.2

1.51

132

986

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

246

1.71

2.77

2.3

2.8

63.6

60.9

pmol/l

0.09

209

(3011335) Digoxin [Mass/volume] in Serum or Plasma

104

2.12

2.73

2.3

2.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

150

1146

1.31

2.67

1.8

1.4

6.6

5.7

u/l

0.37

133

975

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

3.13

2.64

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

127

1.97

2.59

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

124

927

1.34

2.58

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

116

859

1.35

2.57

1.1

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

176

1383

1.27

2.55

1.6

1.9

4.7

3.5

mg/l

2.33

165

1316

(3010370) Gastrin [Moles/volume] in Serum or Plasma

307

1.60

2.54

1.9

39.3

48.7

pmol/l

0.39

262

(3027874) Urate [Moles/volume] in Urine

2.60

2.52

1.2

1.0

1.3

1.6

mmol/l

—

(3019174) dRVVT (LA screen)

195

1.74

2.45

1.2

—

(40768806) Pleura Pathology biopsy report

181

1435

1.26

2.45

1.7

1.5

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

144

1.88

2.45

1.4

7.7

17.0

pmol/l

1.35

124

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

166

1.81

2.43

1.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

101

739

1.37

2.43

1.1

95.9

90.7

1.03

327

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

423

1.49

2.42

1.4

1.3

35.8

41.0

0.42

284

(21494815) CD4 cells/100 lymphocytes in Specimen

211

1706

1.24

2.41

1.9

2.3

44.0

43.1

0.17

225

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

482

1.45

2.38

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.75

2.37

1.1

0.1

0.2

g/l

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

450

1.47

2.36

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

475

1.45

2.35

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

306

1.57

2.34

1.2

1.4

72.1

112.8

ng/l

0.67

193

(3023420) DNA double strand Ab [Units/volume] in Serum

268

2230

1.20

2.33

1.5

1.6

35.1

31.8

iu/ml

0.18

112

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

363

1.52

2.30

1.2

—

(3023410) Appearance of Cerebral spinal fluid

246

2033

1.21

2.30

1.4

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

157

1235

1.27

2.29

1.1

1.3

1.0

u/l

0.48

528

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3757

39238

0.95

2.26

3.9

4.1

22.9

21.7

3.58

1561

18388

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

3.10

2.22

1.1

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

308

2609

1.18

2.21

1.7

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

329

3847

0.85

2.19

1.6

1.5

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

179

1440

1.24

2.18

2.4

2.7

928.6

702.7

e6/l

3.21

576

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

296

1.56

2.17

7.1

7.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

704

1.35

2.15

2.9

2.4

132.0

152.9

nmol/l

1.51

615

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

181

1.71

2.14

1.3

92.5

247.4

u/l

0.45

136

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

411

1.46

2.13

1.2

1.1

—

(3047185) IgG [Mass/volume] in Urine

2.70

2.10

1.1

1.0

—

45.2

—

(3014051) Protein [Presence] in Urine by Test strip

478

4207

1.14

2.09

2.2

2.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

178

1440

1.24

2.08

1.3

1.4

13.7

11.5

umol/l

3.37

165

1369

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

209

1720

1.22

2.07

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

268

1.57

2.07

1.2

1.5

469449.2

272181.8

nmol/l

0.24

230

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

246

2058

1.20

2.06

3.1

3.3

5.0

8.7

nmol/l

0.73

233

1996

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

684

1.35

2.06

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

2.32

2.04

4.2

7.2

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

105

1371

0.76

2.04

1.2

1.3

1.4

1.5

g/l

—

(4027681)

176

1427

1.24

2.02

1.2

1.3

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.81

1.99

1.0

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.96

1.99

3.2

3.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

122

950

1.29

1.98

1.5

1.6

656005.6

1895875.4

iu/ml

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

119

1.85

1.96

1.2

1.4

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

119

1.85

1.96

1.0

1.1

0.7

1.1

u/ml

0.19

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

3.75

1.93

1.0

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.73

1.93

1.9

5.2

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

157

1.72

1.91

1.2

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

447

1.41

1.89

1.0

1.1

2.8

1.8

u/ml

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

298

2557

1.17

1.89

1.7

7808.0

2222.3

titre

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

124

1559

0.79

1.81

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

656

1.33

1.81

2.4

2.9

30.3

28.4

umol/l

0.91

513

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

257

2188

1.18

1.81

1.2

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.26

1.80

1.0

1.2

1556.6

3518.6

ng/l

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.06

1.80

1.7

1.6

0.0

0.1

u/l

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

369

4204

0.88

1.78

1.3

3.8

3.5

ug/l

0.26

334

3809

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.22

1.73

1.1

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

110

1.82

1.72

1.3

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

155

1.68

1.71

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

155

1.68

1.71

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

125

1.76

1.71

3.0

5.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

661

0.70

1.70

1.2

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

242

1.53

1.69

1.0

0.0

0.2

u/ml

1.86

140

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

242

1.53

1.69

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.95

1.69

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

203

1.58

1.67

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

502

1.36

1.65

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1216

13003

0.93

1.65

1.6

1.7

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

351

1.43

1.63

1.2

1.5

0.2

0.3

nmol/l

1.01

252

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2725

28439

0.95

1.63

2.8

2.9

0.7

ug/l

2.87

1808

18204

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

245

1.51

1.61

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

230

1965

1.17

1.59

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.06

1.59

1.1

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

363

1.41

1.56

1.5

1.2

417.3

263.1

ug/l

0.15

200

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

772

1.27

1.53

1.1

273.6

487.4

ng/l

0.49

174

(3044336) Cobalt [Moles/volume] in Urine

0.00

1.52

0.0

2.6

—

24.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

755

1.27

1.52

1.2

1.1

120.2

109.3

1.74

676

(3041672) Baker's yeast Ab [Presence] in Serum

125

0.40

1.49

1.0

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.43

1.47

1.0

2.1

2.6

2.3

mu/l

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

109

1.74

1.46

1.4

1.7

221.3

162.2

ug/g

0.60

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

385

1.38

1.46

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

401

3590

1.12

1.44

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

586

1.30

1.42

1.7

2.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

501

1.32

1.38

1.2

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.08

1.38

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

222

1.49

1.37

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

222

1.49

1.37

1.0

0.0

0.3

u/ml

0.85

122

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

347

1.38

1.37

2.1

4.9

47.8

63.3

u/l

0.49

119

(3021691) Plasmodium malariae Ab [Titer] in Serum

2.61

1.36

2.2

—

(4133840)

555

1.30

1.36

1.1

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

109

884

1.23

1.36

1.1

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

442

1.34

1.36

1.1

—

(3014345) clomiPRAMINE [Moles/volume] in Serum or Plasma

2.94

1.36

1.6

4.1

389.0

283.3

nmol/l

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

125

1029

1.22

1.35

1.1

1486.6

1490.6

miu/ml

0.01

125

1029

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

900

8394

1.08

1.35

1.4

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

936

0.78

1.34

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

207

1.50

1.34

1.0

0.0

0.5

u/ml

1.78

116

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

224

1.47

1.32

1.1

1.2

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

152

1.58

1.31

1.0

2.6

1.3

u/ml

0.20

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

225

1.47

1.30

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

193

1.50

1.28

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

387

1.34

1.27

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.29

1.26

2.5

2.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.05

1.26

2.2

1.3

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

227

1.45

1.25

1.0

0.0

1.9

u/ml

0.57

119

(3035933) Granulocytes/100 leukocytes in Blood

633

0.74

1.25

1.6

1.8

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.40

1.24

2.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

2.40

1.24

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.40

1.24

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.40

1.24

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.40

1.24

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.40

1.24

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.40

1.24

2.0

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

179

1.51

1.23

1.7

1.6

0.7

2.1

mg/l

2.42

116

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

220

1.46

1.22

1.0

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1396

14695

0.95

1.22

1.7

1.8

—

(3049233) Organic acids panel - Urine

2.63

1.21

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

592

1.27

1.21

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

727

1.24

1.20

1.1

99.8

92.9

0.90

328

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

772

1.23

1.20

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

791

1.23

1.19

1.5

2.3

24.3

29.3

3.62

746

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

197

1.47

1.18

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

149

1.54

1.16

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

1.14

0.0

2.3

—

19.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

450

4116

1.10

1.13

1.4

1.5

0.3

0.4

nmol/l

4.14

352

3235

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.33

1.12

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

151

1.52

1.11

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

319

1.35

1.10

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

485

1.28

1.10

2.1

2.8

89.9

108.0

ng/l

0.38

263

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2468

23835

1.04

1.08

1.5

1.4

—

(3013637) Mi-2 Ab [Presence] in Serum

487

1.27

1.07

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

487

1.27

1.07

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

487

1.27

1.07

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

487

1.27

1.07

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

432

3957

1.09

1.07

1.1

1.7

2.3

u/ml

0.64

106

986

(3011841) English Walnut IgE Ab [Units/volume] in Serum

227

1.41

1.07

1.0

6.5

1.7

u/ml

0.33

169

(3049242) von Willebrand panel - Platelet poor plasma

1.86

1.07

1.5

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

202

1.44

1.07

2.1

2.2

0.9

0.6

u/field

0.52

202

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

776

1.21

1.05

1.8

184.0

155.8

1.64

730

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1806

18802

0.96

1.04

1.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

145

1246

1.16

1.04

2.6

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

195

1.44

1.04

1.3

1.1

—

(3034614) HLA Ag [Interpretation]

1.92

1.02

1.0

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

256

1.37

1.00

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.94

0.97

2.9

1.3

1.9

2.1

mmol/24h

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

108

1.57

0.96

1.1

1.0

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

174

1.44

0.94

1.6

2.2

2.0

mg/l

0.05

127

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

174

1.44

0.94

1.6

2.1

1.4

mg/l

0.39

126

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

174

1.44

0.94

1.6

0.9

1.0

mg/l

0.10

107

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

174

1.44

0.94

1.6

3.2

3.9

mg/l

0.25

109

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

174

1.44

0.94

1.6

0.9

2.4

mg/l

2.21

116

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

174

1.44

0.94

1.6

1.4

2.6

mg/l

0.73

120

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

174

1.44

0.94

1.6

0.4

1.1

mg/l

1.29

116

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

174

1.44

0.94

1.6

1.2

2.4

mg/l

1.20

115

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

174

1.44

0.94

1.6

0.5

2.0

mg/l

3.51

107

(3019768) Coxiella burnetii Ab [Presence] in Serum

117

1.54

0.93

1.2

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

183

1.42

0.93

1.6

1.5

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1073

0.84

0.92

1.7

—

(21494434) Karyotype in Bone marrow

157

1373

1.14

0.92

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

261

1.34

0.90

1.3

1.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

118

1.53

0.90

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

349

0.72

0.90

2.8

2.4

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.75

0.90

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

794

8399

0.94

0.89

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

796

8418

0.94

0.89

1.5

1.4

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

160

1.44

0.88

1.0

1.1

—

2.3

—

(3010937) Rubella virus Ab [Presence] in Serum

152

1.45

0.87

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

797

8422

0.94

0.87

1.5

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

848

8038

1.06

0.87

1.3

182.0

231.1

miu/ml

3.82

321

3907

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.00

0.87

1.0

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.94

0.84

1.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

129

1.47

0.83

1.0

—

(3022475) Manganese [Moles/volume] in Blood

141

0.57

0.82

1.0

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

634

1.20

0.82

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

113

1.50

0.82

1.0

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

372

3438

1.08

0.81

1.2

1.1

13.5

11.0

au/ml

0.25

232

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

794

8367

0.95

0.81

1.5

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

130

1.46

0.80

1.0

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

220

1986

1.11

0.80

4.0

4.7

124.0

105.5

u/ml

0.14

623

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

527

1.22

0.79

1.5

1.6

—

429.1

iu/ml

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

321

1.28

0.78

1.1

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

362

0.75

0.78

1.4

1.6

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.59

0.78

1.1

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

748

0.83

0.76

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.64

0.75

1.3

1.2

1.7

1.3

4.64

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

160

1426

1.12

0.75

1.2

1.1

—

(3014891) Appearance of Pleural fluid

158

1.39

0.74

1.8

1.7

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

201

1.34

0.74

1.4

1.3

13.6

11.5

0.13

102

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

128

1126

1.14

0.74

1.2

1.3

—

(3017509) Phencyclidine [Presence] in Urine

254

1.30

0.73

2.3

1.6

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

176

1.36

0.72

1.3

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

159

1.38

0.72

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.67

0.72

1.2

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

230

1.30

0.69

1.0

4.8

1.4

u/ml

0.34

175

(3045683) HLA typing for celiac disease panel - Blood or Tissue

156

1398

1.12

0.68

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

144

1.39

0.67

1.0

1.1

16.8

12.8

iu/ml

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

770

1.16

0.67

1.7

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

770

1.16

0.67

1.7

1.5

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

119

1.43

0.66

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

355

3310

1.07

0.66

1.1

3.9

2.9

u/ml

0.48

146

1698

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

119

1343

0.89

0.66

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

113

997

1.13

0.65

1.2

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

103

1.46

0.64

1.1

1.9

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

137

1.39

0.64

1.7

1.4

24.4

36.4

0.62

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.47

0.64

1.1

1.4

—

(3018291) Platelet Ab [Presence] in Serum

1.72

0.64

1.2

1.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

181

1644

1.10

0.63

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

437

0.80

0.63

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

437

0.80

0.63

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

437

0.80

0.63

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

181

1645

1.10

0.63

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

608

1.17

0.62

1.4

1.5

—

(4035726)

1639

15914

1.03

0.61

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

113

1.42

0.61

1.1

1.4

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

398

1.21

0.60

1.0

1.1

0.1

3.7

u/ml

1.73

289

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.60

0.0

1.2

—

(3020650) Glucose [Presence] in Urine

546

1.17

0.59

1.3

1.4

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

180

1642

1.10

0.59

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

344

0.78

0.58

2.7

3.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

210

1.29

0.58

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

182

1663

1.10

0.58

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

343

0.79

0.57

5.3

6.0

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.71

0.57

1.2

1.3

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.71

0.57

1.0

—

(3000285) Sodium [Moles/volume] in Blood

202

1.29

0.57

1.2

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

115

1.39

0.56

1.2

1.3

—

(3006598) pH of Arterial cord blood

1.45

0.56

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

606

1.16

0.55

1.5

2.3

344.4

323.9

e6/l

0.04

330

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

181

1660

1.09

0.54

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

117

1302

0.90

0.54

1.1

1.0

0.4

1.0

u/ml

0.57

165

(3045142) Bone marrow Pathology biopsy report

198

1824

1.09

0.54

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

181

1661

1.09

0.54

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

330

1.21

0.54

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

277

1.23

0.52

1.3

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

171

1.29

0.49

1.1

18.5

23.0

u/l

0.65

112

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

864

8948

0.96

0.49

1.5

—

(3015183) Erythrocyte sedimentation rate

130

1182

1.10

0.49

1.3

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.43

0.49

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

253

1.23

0.48

1.1

1.0

—

(3007733) Chloride [Moles/volume] in Urine

1.43

0.46

1.1

1.7

76.9

81.5

mmol/l

—

(3013862) HLA-DP [Type]

0.61

0.45

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.60

0.45

1.4

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.40

0.45

1.1

—

(4038314)

1.40

0.44

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

705

1.12

0.43

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

336

3187

1.06

0.43

1.1

6.6

4.8

u/ml

0.40

138

1329

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

388

1.16

0.41

1.1

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.6

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.40

0.0

1.8

—

15.7

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

114

1.32

0.40

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

216

0.79

0.40

1.6

3.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.36

0.40

1.2

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

134

1237

1.08

0.39

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

223

1.21

0.39

1.6

1.4

7.5

7.2

mmol/l

0.13

(3034426) Prothrombin time (PT)

759

1.11

0.39

1.3

1.2

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.38

0.38

1.1

8.2

8.4

0.09

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.38

0.38

1.3

1.1

19.9

21.1

0.35

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

188

1.22

0.37

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.35

0.37

1.0

—

(40758292) HTLV I+II Ab panel - Serum

333

0.84

0.37

1.1

1.4

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

125

1.28

0.36

1.3

1.4

14.4

19.0

pmol/l

0.83

102

(3013293) Extractable nuclear Ab [Presence] in Serum

337

1.16

0.36

1.5

1.6

—

(40760409) HLA-A [Type] by High resolution

0.63

0.35

1.0

—

(40763590) HLA-DQ beta [Type]

0.63

0.35

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.63

0.35

1.0

—

(40760410) HLA-B [Type] by High resolution

0.63

0.35

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

153

1429

1.07

0.35

1.1

0.6

1.4

u/ml

1.15

389

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

470

1.13

0.35

1.2

75.4

70.4

—

126

(3026726) Creatinine [Moles/volume] in Specimen

154

1.23

0.33

2.5

2.4

232.9

393.1

umol/l

0.68

147

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

1.32

0.33

1.1

1.3

—

10925.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

939

0.92

0.33

5.9

6.2

7865.1

4207.0

u/ml

0.17

193

(40768795) Lymph node Pathology biopsy report

173

1838

0.94

0.33

1.1

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

771

7925

0.97

0.33

2.2

1.9

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

188

0.80

0.33

1.9

2.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

231

2194

1.05

0.32

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

192

1.20

0.32

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

578

5603

1.03

0.31

1.5

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

133

1246

1.07

0.30

5.9

6.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

121

1.24

0.28

1.1

1.4

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

129

0.78

0.28

1.3

1.2

0.2

3.8

u/ml

—

106

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

172

1812

0.95

0.27

3.5

3.9

51.9

46.9

u/ml

0.13

166

1799

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

471

1.10

0.26

1.2

1.1

103.5

83.7

1.63

129

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.70

0.26

1.8

3.9

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.30

0.26

14.9

14.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.68

0.26

1.8

4.1

—

(3013762) Body weight Measured

0.67

0.25

1.0

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

446

0.90

0.25

1.1

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

127

0.79

0.25

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

115

1083

1.06

0.24

1.0

230.5

346.2

ng/l

2.75

783

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.25

0.24

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

392

0.89

0.24

1.4

2.0

2.9

ug/l

0.52

228

(3009677) Dengue virus Ab [Presence] in Serum

0.71

0.24

1.0

1.2

—

(4212803)

143

1.19

0.23

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

834

1.07

0.22

3.2

3.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

691

0.93

0.22

1.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

285

2754

1.04

0.22

1.1

1.0

0.1

0.5

u/ml

1.80

578

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

115

1088

1.06

0.22

1.0

875.0

735.7

ng/l

2.35

761

(3014133) Dog dander IgE Ab [Units/volume] in Serum

351

3407

1.03

0.21

1.1

6.5

4.8

u/ml

0.42

148

1320

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

286

1.12

0.21

2.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.21

0.0

1.8

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.21

0.0

2.3

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.16

0.21

1.4

1.1

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

768

7536

1.02

0.20

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

115

1091

1.05

0.20

1.0

30.8

40.8

ng/l

4.49

770

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.20

0.0

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.20

0.0

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

365

0.90

0.19

2.1

2.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

302

0.89

0.19

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

346

1.10

0.19

4.1

6.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

185

1.14

0.18

1.0

1.1

2.5

1.7

umol/24h

1.44

185

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

112

1.16

0.14

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

778

0.95

0.14

1.7

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

139

0.86

0.14

1.0

1.1

6.4

6.8

u/ml

—

101

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

377

0.93

0.13

1.1

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

109

1132

0.96

0.13

2.2

2.8

43.7

39.0

1.54

383

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

138

0.87

0.13

1.6

2.7

—

(40765096) Chromosome analysis panel by Banding

478

0.94

0.12

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

158

0.89

0.12

2.6

3.9

2.7

2.2

mg/l

—

137

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

289

1.07

0.11

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

141

1371

1.03

0.11

1.6

1.3

73.7

85.6

pmol/l

0.15

434

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

134

1.12

0.10

1.9

2.6

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

163

1670

0.98

0.10

1.4

25.5

32.5

nmol/l

2.97

141

1544

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

526

1.05

0.09

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

114

0.88

0.09

1.3

6.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

155

1.10

0.09

1.1

1.0

0.1

0.8

u/ml

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.11

0.09

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.79

0.08

5.6

3.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.78

0.08

1.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

123

0.89

0.08

5.9

4.9

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.06

0.08

1.0

1.1

226.3

238.5

nmol/l

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.04

0.08

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.86

0.07

1.7

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.86

0.07

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

123

1258

0.98

0.07

1.5

—

(3046861) Legionella sp Ag [Presence] in Urine

1.06

0.07

1.3

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.88

0.06

1.4

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

275

0.95

0.06

1.1

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

294

0.95

0.06

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

377

1.03

0.04

1.1

1.2

0.1

3.0

u/ml

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

143

1412

1.01

0.04

1.1

1.0

0.7

2.5

u/ml

1.99

330

(3020123) Porphyrins [Interpretation] in Serum or Plasma

129

0.93

0.03

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

131

1.07

0.03

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

231

1.04

0.02

1.2

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

128

0.94

0.02

1.3

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

381

3827

1.00

0.02

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

272

1.03

0.02

1.5

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

677

0.99

0.01

1.1

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

106

0.94

0.01

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

124

1.05

0.00

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

204

1.03

0.00

1.2

1.4

—

(3007463) Buprenorphine [Presence] in Urine

105

0.95

0.00

6.3

7.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

208

1.01

0.00

1.3

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

1.02

0.00

1.0

18.9

10.4

u/ml

—

(3016072) Theophylline [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.6

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.0

4.6

—

140.8

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.0

2.5

—

4.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.00

0.00

2.0

5.7

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.1

—

(3025311) HLA-B [Type]

0.00

0.0

1.0

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3004768) Phthalic anhydride IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.0

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.93

0.00

6.6

9.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

240

1.00

0.00

2.5

2.6

—

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

0.00

0.0

2.3

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_OBESITYCAL and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_OBESITYCAL	2.147 [1.93, 2.39]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.058

During the follow-up period (1.1.1998 — 31.12.2019), 6161 out of 66711 females with E4_OBESITYCAL died.

Males

Parameter	HR [95% CI]	p-value
E4_OBESITYCAL	2.061 [1.87, 2.28]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.011

During the follow-up period (1.1.1998 — 31.12.2019), 7553 out of 48217 males with E4_OBESITYCAL died.

Mortality risk

Mortality risk for people of age

years, who have E4_OBESITYCAL.

N-year risk	Females	Males
1	0.208%	0.501%
5	1.284%	2.372%
10	3.008%	5.888%
15	5.484%	11.39%
20	9.308%	18.689%

Relationships between endpoints

↥

Index endpoint: E4_OBESITYCAL – Obesity due to excess calories

GWS hits: 40

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Obesity due to excess calories

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints